hg_95593.1

Basic information about the TSS

---

TSS ID: hg_95593.1 Species: human Chr: chr8		Start: 143976722 End: 143976767 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000436759.6 ENST00000527303.2 U53204 Distance: 0 GeneID: 5339 HGNC/MGI_ID: HGNC:9069 UniProt_ID: H0YDN1 Q15149

Gene_name: plectin Gene_symbol: PLEC Gene_synonyms: PCN PLTN Gene_source: HGNC:9069

TATA-Box annotation

---

Distance to TSS:	0
Nearest PromoterID:	NM_000445
Entrez ID:	5339
Nearest Unigene:	Hs.434248
Nearest Refseq:	NM_000445
Nearest Ensembl:	ENSG00000178209
Gene Name:	plectin
Gene Alias:	EBS1|EBSMD|EBSND|EBSO|EBSOG|EBSPA|HD1|LGMD2Q|LGMDR17|PCN|PLEC1|PLEC1b|PLTN
Gene Description:	plectin
Gene Type:	protein-coding
CpG%:	0.145
GC%:	0.79602
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PLEC p2@PLEC p3@PLEC p4@PLEC p5@PLEC p6@PLEC p7@PLEC p8@PLEC p9@PLEC
Sample		p1@PLEC	p2@PLEC	p3@PLEC	p4@PLEC	p5@PLEC	p6@PLEC	p7@PLEC	p8@PLEC	p9@PLEC
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	0.19	0.00	1.56	5.26	0.39	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	0.20	0.00	1.82	5.06	0.40	0.00	0.00	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	0.19	0.00	1.93	6.37	0.39	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	0.21	0.00	1.25	5.41	0.62	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	0.45	0.00	0.45	4.95	0.22	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	0.58	0.00	1.74	6.20	0.19	0.00	0.19	0.39	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	0.44	0.00	1.31	4.58	0.65	0.22	0.00	0.00	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	0.00	0.00	0.24	4.60	0.48	0.00	0.00	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	0.21	0.00	1.07	5.13	0.21	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	0.00	0.00	1.16	6.96	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	0.00	0.00	0.00	4.04	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	0.00	0.00	0.81	2.85	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	29.18	3.71	7.41	14.51	5.32	2.90	1.61	4.51	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	20.60	3.16	5.41	8.42	4.36	3.91	1.05	5.71	5.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	21.30	3.07	4.17	9.22	4.83	3.73	1.10	3.73	3.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	19.87	4.28	2.51	10.06	4.02	3.52	1.51	4.28	2.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	24.90	2.84	5.46	8.74	2.62	3.28	1.09	3.28	2.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	16.03	4.22	6.75	6.75	4.22	1.69	0.84	3.80	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	31.99	2.67	6.40	13.33	4.27	3.73	1.07	5.86	4.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	24.82	4.36	5.57	16.25	5.42	2.26	0.75	5.57	4.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	29.27	3.47	6.01	15.64	4.68	3.88	3.34	5.35	5.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	31.24	4.83	7.25	18.30	4.14	3.97	2.42	6.39	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	32.18	2.84	7.88	17.06	4.52	2.59	1.29	4.27	5.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	38.83	6.55	5.58	15.77	3.88	3.15	2.43	4.61	5.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	32.76	6.19	6.19	23.74	6.71	0.77	3.35	8.00	3.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	25.95	5.38	1.58	18.36	4.43	5.38	2.53	4.75	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	41.76	4.40	4.40	21.43	3.30	2.75	2.20	7.69	6.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	38.43	6.84	7.31	43.14	6.60	4.24	3.54	6.13	5.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	34.40	4.36	6.14	31.82	3.88	2.91	1.45	5.33	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	36.19	5.61	5.79	31.67	4.52	5.43	1.63	7.60	3.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	30.56	3.77	5.65	24.70	4.19	3.77	1.88	5.02	2.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	26.38	3.52	3.52	24.62	5.47	4.10	2.34	4.49	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	25.96	3.80	3.80	27.64	3.80	3.17	1.69	5.49	3.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	22.43	2.97	4.62	26.06	3.13	1.81	0.66	3.46	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	30.85	4.11	4.30	25.06	3.37	2.99	0.93	3.74	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	27.98	4.22	5.75	29.89	3.83	4.41	2.68	3.64	4.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	27.59	4.70	4.70	25.14	4.50	2.66	1.02	4.29	3.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	30.22	5.24	5.24	25.79	5.84	2.82	0.81	3.22	4.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	29.44	5.13	8.10	19.18	4.05	1.89	1.62	4.86	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	31.69	4.56	6.48	25.69	3.12	5.04	1.44	4.80	2.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	32.70	5.65	6.12	26.35	4.94	2.35	1.41	3.53	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	24.89	2.64	4.39	26.50	3.22	2.64	1.61	2.78	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	32.69	2.95	6.75	29.53	4.22	1.05	1.05	3.80	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	30.77	3.85	5.24	27.80	4.20	2.45	1.57	2.27	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	36.14	3.41	6.02	25.50	4.62	2.21	2.01	4.82	2.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	33.73	3.95	4.42	23.96	4.19	2.33	2.09	5.35	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	33.59	6.24	6.96	30.47	4.56	3.36	2.16	3.12	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	34.87	1.79	4.47	22.65	3.58	2.68	1.79	3.87	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	32.79	2.39	3.59	33.75	4.79	3.11	1.91	3.59	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	31.54	4.04	5.86	30.73	4.04	2.83	1.42	4.25	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	26.23	3.48	5.53	39.97	5.12	3.48	1.02	5.12	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	34.91	3.11	5.78	38.47	5.11	3.78	1.56	3.78	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	30.87	2.13	3.55	33.00	4.97	1.77	1.77	4.26	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	29.49	2.98	3.31	40.76	4.31	3.31	2.98	4.97	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	8.39	0.84	2.52	20.13	0.00	0.00	0.84	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	17.91	0.92	2.30	25.26	3.21	1.38	1.38	1.38	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	31.44	1.62	2.27	39.87	4.86	4.21	1.30	3.57	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	31.80	1.93	4.18	31.15	2.25	2.57	1.28	2.89	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	19.17	1.89	3.14	35.83	4.09	3.46	1.26	2.20	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	24.68	2.12	0.71	19.04	3.53	0.71	0.00	3.53	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	25.80	2.80	2.24	26.36	1.68	4.49	2.24	2.80	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.94	2.39	2.39	9.55	2.39	0.00	0.00	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	17.67	1.36	2.72	16.65	2.04	1.36	0.34	1.70	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	25.02	1.30	1.95	27.29	4.87	2.27	1.30	4.22	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	29.46	2.48	3.19	30.88	4.26	4.97	2.48	3.55	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	0.00	23.69	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	77.03	13.16	5.36	40.95	10.73	9.75	8.78	6.34	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	86.78	5.45	7.44	44.63	9.42	6.45	1.98	8.43	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	71.77	12.20	6.57	47.38	12.20	8.44	4.69	11.26	3.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	70.21	9.94	6.62	36.43	9.27	9.27	2.98	8.94	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	76.72	13.92	4.02	34.03	11.75	6.81	4.95	12.37	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	86.83	11.01	5.81	35.47	14.06	11.31	3.97	10.40	1.53
Adipocyte - breast, donor1	11376-118A8	44.66	30.25	10.29	2.38	10.14	2.38	8.55	7.76	1.27
Adipocyte - breast, donor2	11327-117E4	47.97	20.05	10.11	2.89	8.98	3.53	11.23	5.61	2.25
Adipocyte - omental, donor1	11473-119C6	41.73	35.37	8.02	6.36	16.92	2.54	12.98	9.67	1.78
Adipocyte - omental, donor2	11474-119C7	59.05	14.20	8.22	1.49	8.97	4.48	4.48	6.73	2.99
Adipocyte - omental, donor3	11475-119C8	12.73	14.07	6.03	3.01	9.04	0.67	2.34	4.69	1.34
Adipocyte - perirenal, donor1	11476-119C9	21.69	12.76	3.83	0.00	10.85	2.55	5.74	1.91	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	4.40	0.00	3.30	1.10	0.00	2.20	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	4.52	25.29	4.97	2.71	4.52	0.45	4.06	0.90	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	1.91	5.73	6.60	2.26	3.30	0.00	1.04	2.09	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	10.37	10.76	4.50	6.26	3.52	1.76	2.54	3.13	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	5.15	3.35	7.21	3.60	1.54	2.06	1.29	1.03	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	8.36	23.14	6.97	5.58	4.46	0.56	5.58	2.51	2.51
Adipocyte differentiation, day04, donor4	13028-139E4	5.88	8.82	4.70	7.64	1.76	0.59	2.35	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	3.06	3.06	4.67	4.42	0.72	0.40	0.97	1.13	1.37
Adipocyte differentiation, day08, donor2	13023-139D8	2.58	2.26	5.81	4.84	1.94	0.65	0.97	1.29	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	3.20	4.27	3.20	4.80	2.13	0.53	2.13	2.67	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	2.78	2.78	2.78	2.23	1.11	0.00	0.56	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	2.91	4.99	4.16	1.66	2.91	0.42	0.42	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	3.01	2.51	5.53	4.27	0.75	0.75	0.50	0.50	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	1.64	4.25	6.54	2.62	1.64	0.33	2.62	1.96	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	1.83	1.22	4.26	2.44	0.91	0.61	0.61	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	159.78	21.88	15.91	16.80	7.07	18.34	3.76	2.43	1.33
Alveolar Epithelial Cells, donor2	11590-120G6	284.00	23.67	12.91	15.06	3.59	31.56	5.74	2.15	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	51.51	9.58	15.57	8.39	4.79	5.99	2.40	0.00	4.79
Amniotic Epithelial Cells, donor1	11533-120A3	236.94	10.61	23.21	48.03	5.04	9.18	3.42	2.52	2.88
Amniotic Epithelial Cells, donor2	11613-122A2	189.10	11.71	28.45	43.51	3.35	11.71	0.00	3.35	6.69
Amniotic Epithelial Cells, donor3	11694-123A2	255.78	9.45	19.72	46.23	8.22	11.51	4.52	3.08	5.75
Anulus Pulposus Cell, donor1	11248-116E6	134.34	18.08	10.30	4.58	12.13	11.44	3.20	9.73	5.61
Anulus Pulposus Cell, donor2	11463-119B5	261.56	26.21	10.04	4.65	15.18	17.39	7.59	12.98	7.84
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.74	2.70	4.94	2.25	5.39	0.00	1.80	1.80	2.25
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	5.64	6.08	5.21	3.47	2.60	1.30	1.74	3.04	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	6.42	6.42	2.14	0.00	0.00	2.14	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	10.76	5.98	2.99	4.18	4.78	2.39	2.39	2.69	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	2.53	2.53	1.26	3.79	3.79	1.26	2.53	6.32	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	8.58	5.94	3.96	3.96	3.96	0.66	2.64	3.30	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.15	2.60	3.25	3.25	2.27	0.97	0.97	1.30	3.57
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	5.34	3.40	3.40	1.94	4.37	0.97	1.94	1.46	2.43
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.34	4.75	6.53	2.97	5.34	1.19	0.59	1.78	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	5.65	6.40	6.40	3.01	2.64	1.13	1.51	2.26	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	6.53	5.08	2.18	4.35	0.73	0.73	1.45	1.45	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	3.76	1.25	5.02	1.25	0.00	0.00	2.51	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	7.74	3.79	6.26	5.27	7.41	0.66	0.99	3.62	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	5.46	2.73	1.36	4.09	0.00	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	6.33	3.17	4.98	3.92	5.13	1.06	1.06	4.07	1.36
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	3.21	6.97	4.29	4.29	1.07	0.54	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	7.37	3.59	4.53	4.91	3.02	1.51	0.76	3.40	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	7.48	4.81	5.08	6.95	4.01	0.53	1.87	2.14	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	6.83	4.88	3.90	0.00	2.93	1.95	3.90	1.95	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.96	2.99	5.64	4.15	1.82	1.82	1.00	2.32	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	6.00	10.81	2.40	2.40	0.00	0.00	3.60	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	0.00	0.00	10.62	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	6.35	3.43	3.09	5.15	4.29	0.86	1.20	3.26	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19	0.00	12.58	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	4.37	2.43	5.83	2.43	1.94	0.97	1.94	1.46	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	8.35	3.04	6.07	4.93	5.31	1.14	2.66	2.66	2.66
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	2.42	3.63	0.00	2.42	0.00	3.63	3.63	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	7.98	3.99	3.99	3.42	1.14	0.57	0.00	2.85	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	6.84	4.06	4.92	3.42	5.34	1.28	1.28	2.99	1.50
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	6.19	5.16	4.90	3.36	4.65	1.55	2.58	3.10	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	9.85	4.69	3.28	3.75	2.35	0.00	2.82	2.35	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	8.04	4.50	4.82	5.47	3.54	0.00	1.29	2.57	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	5.71	4.99	2.14	4.99	2.14	0.00	1.43	3.57	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	6.43	2.92	2.92	4.09	3.51	1.17	1.17	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.63	4.82	4.82	3.91	3.61	1.20	1.20	3.31	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	5.94	5.94	5.94	10.69	0.00	0.00	9.50	4.75
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	4.58	4.07	2.03	1.53	3.05	1.02	2.03	2.54	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.40	4.08	4.33	4.58	3.31	0.51	0.51	1.02	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.99	5.08	5.08	2.54	5.72	0.64	0.00	3.18	3.81
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.77	6.04	3.45	4.32	4.32	0.00	0.43	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	7.41	4.66	4.23	3.60	3.60	1.06	1.27	3.18	2.33
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.38	4.35	2.90	3.48	4.06	0.87	0.00	1.16	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	12.28	4.72	5.67	4.72	1.89	0.00	1.89	2.83	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	6.27	2.71	4.75	3.39	3.90	1.02	1.36	2.03	1.86
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	2.32	0.00	2.32	0.00	0.00	0.00	6.95	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	2.11	2.11	2.11	4.23	0.00	2.11	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	8.15	3.65	4.29	3.43	2.36	0.64	0.86	3.65	1.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	14.44	4.81	4.21	2.41	2.41	1.80	2.41	0.00	2.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	4.37	2.92	3.64	0.73	0.73	2.19	2.92	0.00	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	6.90	2.30	2.99	5.98	3.68	0.69	0.46	2.76	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	0.00	0.00	15.30	2.55	0.00	0.00	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	7.37	3.31	4.83	3.31	3.56	0.76	1.53	2.80	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	8.46	3.72	3.10	3.10	4.13	0.62	1.65	1.45	1.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.26	3.67	2.14	4.59	2.14	0.61	1.22	1.53	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	3.35	2.87	4.30	3.35	1.91	0.00	0.96	1.91	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.43	1.77	1.77	4.88	2.44	0.22	1.77	2.88	2.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	3.05	1.53	7.63	1.53	3.05	1.53	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	3.88	0.55	1.11	2.77	2.77	0.55	0.55	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	6.88	4.77	3.97	5.56	3.71	0.26	0.53	2.12	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4.36	1.82	1.82	5.09	2.91	1.09	0.36	1.45	0.00
Astrocyte - cerebellum, donor1	11500-119F6	36.72	24.19	12.04	9.95	7.37	3.81	2.58	7.74	8.23
Astrocyte - cerebellum, donor2	11580-120F5	61.10	31.66	9.24	14.21	11.47	7.87	6.16	10.78	7.53
Astrocyte - cerebellum, donor3	11661-122F5	58.52	11.33	10.07	15.52	9.44	9.23	2.94	12.79	10.07
Astrocyte - cerebral cortex, donor1	11235-116D2	4.88	2.44	4.88	8.37	3.49	0.35	0.35	1.05	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	22.32	12.29	5.50	13.10	3.88	2.59	5.50	1.29	4.85
Astrocyte - cerebral cortex, donor3	11392-118C6	35.05	4.62	10.44	12.98	4.92	4.92	0.75	1.64	5.67
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	3.90	0.00	10.21	1.61	0.34	3.78	0.00	0.23	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	3.76	0.00	8.64	2.00	0.50	2.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	3.87	0.00	8.76	1.25	0.34	2.50	0.00	0.11	0.00
Basophils, donor1	12241-129G9	65.12	13.34	21.45	3.66	3.92	5.75	3.14	4.71	2.62
Basophils, donor2	12242-129H1	85.15	8.30	33.19	4.69	5.41	10.82	3.25	10.82	2.89
Basophils, donor3	12243-129H2	163.17	22.05	30.28	3.82	6.32	11.47	4.70	10.29	5.00
Bronchial Epithelial Cell, donor1	11511-119G8	301.41	11.43	32.77	11.86	6.68	14.45	1.29	2.59	2.37
Bronchial Epithelial Cell, donor2	11591-120G7	657.89	21.49	36.57	36.57	11.43	49.38	5.03	1.37	5.94
Bronchial Epithelial Cell, donor3	11672-122G7	301.29	0.00	14.35	0.00	0.00	7.17	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	195.20	6.90	6.90	16.32	4.39	15.69	3.77	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	288.01	12.89	13.93	22.87	5.82	22.46	4.57	1.04	2.08
Bronchial Epithelial Cell, donor6	11461-119B3	371.69	13.36	13.13	20.96	5.76	20.50	3.45	1.38	1.38
Bronchial Epithelial Cell, donor7	11769-123I5	211.98	7.38	17.27	9.36	4.50	13.50	0.54	0.36	2.16
Burkitt's lymphoma cell line:DAUDI	10422-106C8	2.16	0.00	0.00	1.85	2.47	2.78	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	3.73	0.00	5.12	0.47	1.40	2.10	0.00	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	0.96	0.00	1.60	0.00	2.24	0.00	0.00	2.56	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	10.34	0.00	0.00	0.00	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	149.91	10.71	29.30	4.51	8.45	13.53	2.82	11.83	3.94
CD14+ Monocytes, donor2	11305-117B9	215.30	21.34	31.92	2.78	7.24	15.03	7.80	8.35	2.97
CD14+ Monocytes, donor3	11381-118B4	121.84	13.39	28.32	3.07	12.51	10.10	4.39	9.66	4.17
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	52.93	2.26	22.36	1.13	0.85	5.66	2.26	1.70	2.26
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	89.84	7.20	25.02	2.27	4.17	12.51	3.03	3.03	3.41
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	100.92	3.62	26.96	0.99	1.97	16.44	2.30	4.93	1.97
CD14+ monocytes - mock treated, donor1	11863-125A9	263.80	47.12	16.33	6.94	6.94	16.48	25.30	13.44	4.05
CD14+ monocytes - mock treated, donor2	11873-125C1	192.51	31.98	16.29	5.43	3.62	9.05	11.47	9.66	3.02
CD14+ monocytes - mock treated, donor3	11883-125D2	249.45	40.03	16.58	9.24	6.40	18.00	19.19	11.37	2.84
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	215.94	46.54	12.39	7.37	3.52	11.38	15.57	8.20	1.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	183.00	29.81	7.18	11.32	4.97	11.59	9.38	4.14	1.93
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	185.95	44.13	8.68	14.88	3.22	15.37	11.16	7.44	1.49
CD14+ monocytes - treated with BCG, donor1	11860-125A6	137.84	22.71	9.20	5.29	2.35	10.57	9.01	5.09	1.57
CD14+ monocytes - treated with BCG, donor2	11870-125B7	179.12	22.43	11.57	5.16	2.31	13.00	10.86	5.52	1.07
CD14+ monocytes - treated with BCG, donor3	11880-125C8	169.97	20.67	9.58	10.45	2.39	8.49	6.53	4.13	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	90.14	19.20	7.02	6.56	2.34	6.09	9.60	4.92	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	123.56	17.95	11.09	8.98	2.64	11.62	5.81	3.70	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	116.48	16.64	9.98	21.08	2.22	12.20	4.44	3.33	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	210.93	42.24	13.24	7.14	6.69	15.47	15.92	8.03	3.12
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	209.53	27.74	7.98	8.38	5.59	15.96	9.78	4.99	2.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	176.55	21.86	8.54	12.70	3.12	10.41	6.04	4.58	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	213.91	40.49	11.44	13.04	4.80	15.56	17.62	7.78	3.43
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	184.13	20.13	10.86	12.67	4.52	10.63	8.37	4.75	1.58
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	162.36	27.06	8.73	17.89	3.93	10.91	7.86	3.93	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	144.99	18.56	12.37	5.11	4.57	11.30	9.95	3.50	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	213.54	16.92	13.96	7.15	3.84	16.05	11.34	6.98	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	220.09	20.20	12.20	7.57	4.21	21.04	7.15	5.47	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	267.67	27.92	5.88	7.35	5.51	19.84	9.55	3.67	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	264.55	18.67	3.52	16.91	2.47	14.80	3.17	2.47	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	250.07	21.06	7.02	21.94	1.32	15.79	7.46	3.95	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	109.16	22.67	7.32	6.45	2.44	10.99	7.85	4.88	1.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	142.35	25.65	13.01	7.81	1.49	15.24	9.29	2.97	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	155.84	28.88	13.80	12.93	4.74	12.07	10.35	5.17	1.94
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	164.20	20.06	6.55	8.60	2.05	9.42	6.55	3.69	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	181.50	12.98	6.72	15.53	3.01	16.69	3.71	3.01	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	187.22	14.38	3.94	25.29	2.55	10.21	3.94	1.39	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	33.57	13.08	15.91	1.53	3.05	1.96	1.53	4.36	1.53
CD14+CD16+ Monocytes, donor2	11801-124D1	46.66	16.63	15.01	1.15	5.54	2.54	3.23	5.31	4.16
CD14+CD16+ Monocytes, donor3	11912-125G4	30.33	8.45	13.65	0.65	2.82	3.03	1.30	3.25	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	55.90	12.77	36.44	2.02	5.45	2.65	3.58	6.85	6.23
CD14+CD16- Monocytes, donor2	11799-124C8	54.31	12.05	28.64	2.45	5.06	5.94	1.57	5.76	2.79
CD14+CD16- Monocytes, donor3	11910-125G2	40.58	7.80	31.22	2.01	4.68	7.14	1.78	4.01	4.46
CD14-CD16+ Monocytes, donor1	11790-124B8	39.04	16.84	22.46	1.02	7.91	1.28	1.79	8.68	2.55
CD14-CD16+ Monocytes, donor2	11800-124C9	26.35	18.22	14.49	1.10	7.25	0.66	1.76	9.00	4.39
CD14-CD16+ Monocytes, donor3	11911-125G3	19.79	12.42	14.11	0.84	7.16	0.84	1.05	4.21	2.32
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	42.68	0.00	18.29	2.03	8.13	6.10	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	56.27	0.00	11.53	0.00	6.78	5.42	0.00	4.07	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	41.42	0.00	13.46	0.00	7.25	6.21	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	49.04	0.00	17.06	2.13	13.33	4.80	0.00	4.26	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	51.46	0.00	16.08	0.00	6.97	8.58	0.00	1.61	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	35.10	0.00	16.14	0.70	3.51	7.02	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	44.71	0.00	18.04	1.57	8.63	5.49	0.00	2.35	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	42.19	0.00	11.86	0.00	11.86	9.23	0.00	3.95	0.00
CD19+ B Cells, donor1	11544-120B5	54.25	0.82	12.33	0.82	7.40	9.04	0.00	3.29	0.00
CD19+ B Cells, donor2	11624-122B4	39.17	0.00	13.06	0.00	6.53	5.80	0.00	2.18	0.73
CD19+ B Cells, donor3	11705-123B4	48.46	0.00	12.62	0.50	7.57	4.54	0.00	2.02	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.40	0.00	0.40	0.40	0.00	0.00	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.40	0.00	0.80	0.40	0.40	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	12.05	2.01	2.01	0.00	2.01	1.00	0.00	3.01	0.00
CD34+ Progenitors, donor2	11625-122B5	85.39	10.67	8.43	5.06	3.93	11.24	0.00	6.18	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	0.38	0.00	1.50	0.00	0.75	0.38	0.00	1.13	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	1.13	0.00	1.35	0.00	0.68	0.00	0.00	0.90	0.00
CD4+ T Cells, donor1	11225-116C1	74.98	0.71	32.85	12.14	15.35	6.07	0.00	8.21	0.00
CD4+ T Cells, donor2	11306-117C1	115.74	1.22	30.01	14.08	18.37	14.70	0.00	9.80	0.00
CD4+ T Cells, donor3	11382-118B5	109.49	1.52	30.80	4.27	22.26	14.33	0.00	19.21	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	80.14	0.26	11.74	0.77	9.70	6.89	0.00	5.87	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	101.74	0.00	11.23	0.90	7.41	6.74	0.00	4.94	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	91.99	0.00	13.51	0.86	17.82	5.46	0.00	9.20	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	32.71	0.00	18.49	3.32	13.27	2.37	0.00	6.16	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	28.80	0.00	17.56	2.81	14.75	5.62	0.00	7.02	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	0.00	9.89	3.30	9.89	9.89	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	56.65	1.59	6.50	1.01	5.93	4.77	0.00	5.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	145.91	1.36	10.51	1.53	9.32	8.64	0.34	7.96	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	106.40	2.74	7.74	0.48	9.83	8.38	0.48	12.57	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	86.07	1.34	11.66	0.45	6.72	6.28	0.00	3.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	84.20	0.70	15.72	2.10	8.73	6.64	0.00	8.39	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	99.88	2.20	19.36	2.64	14.52	7.48	0.00	14.52	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	39.21	0.00	10.96	1.26	6.32	2.95	0.00	1.26	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	27.01	0.21	4.57	0.83	4.99	2.70	0.00	1.25	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	20.38	0.00	7.68	0.33	5.01	1.67	0.00	2.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	60.10	0.00	60.10	22.84	21.75	5.98	0.27	5.71	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	60.03	0.00	55.74	18.76	22.51	4.82	0.00	5.90	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	48.42	0.00	53.80	5.38	21.52	7.17	0.00	8.97	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	69.16	0.37	12.61	0.00	9.27	7.42	0.37	6.30	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	71.92	0.22	7.36	1.08	5.20	6.50	0.00	3.03	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	63.47	0.00	9.67	0.00	10.72	6.30	0.00	6.09	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	69.27	0.00	33.88	8.60	11.63	10.11	0.00	11.12	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	67.15	0.43	19.93	3.47	11.26	6.50	0.00	3.90	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	53.61	0.00	30.51	2.18	16.56	10.46	0.00	5.67	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	66.81	0.00	55.43	7.92	27.22	8.91	0.00	4.95	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	48.01	0.00	30.47	1.85	24.00	5.54	0.00	11.08	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	55.83	0.00	27.92	4.19	26.52	4.19	0.00	9.77	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	57.05	2.22	28.52	6.37	22.43	8.86	0.00	9.97	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	69.20	0.49	31.41	7.85	21.10	10.80	0.00	10.31	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	113.96	0.00	55.44	4.62	27.72	7.70	0.00	9.24	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	75.92	0.72	47.63	6.09	17.19	11.82	0.00	11.82	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	66.48	0.00	38.78	4.15	15.23	6.92	0.00	12.46	0.00
CD8+ T Cells, donor1	11226-116C2	95.93	1.31	33.07	4.91	18.33	7.20	0.65	13.10	0.00
CD8+ T Cells, donor2	11307-117C2	112.25	0.75	26.28	8.26	18.02	10.14	0.75	12.76	0.00
CD8+ T Cells, donor3	11383-118B6	56.56	0.50	32.57	7.57	17.93	5.30	0.00	9.85	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	2.29	11.01	4.36	0.00	0.69	0.00	2.06	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	2.16	9.35	4.31	0.24	0.96	0.48	2.40	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	3.28	9.85	3.01	0.00	0.55	0.27	1.37	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.60	11.71	2.70	0.00	0.60	0.60	2.10	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	4.32	12.48	4.80	0.00	0.96	0.72	3.36	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	2.05	10.69	3.41	0.00	0.00	0.91	1.14	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	1.96	9.56	3.91	0.00	0.87	0.22	1.09	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	2.90	10.00	2.63	0.00	0.53	0.26	2.11	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	3.05	10.79	1.88	0.00	0.47	0.23	2.35	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	1.21	6.64	2.42	0.00	0.60	0.60	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	1.74	10.46	3.49	0.00	0.58	0.00	1.45	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	0.27	6.93	2.93	0.00	0.00	0.80	1.33	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.94	9.63	4.38	0.00	1.75	0.44	3.50	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	2.28	10.02	5.47	0.00	2.73	0.46	3.64	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	3.73	7.46	2.24	0.00	2.24	0.75	0.75	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	2.16	15.49	3.60	0.00	1.44	0.72	2.52	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.03	14.96	4.60	0.00	1.15	1.15	3.74	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.71	17.68	5.19	0.00	0.47	0.24	2.83	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	2.85	9.19	4.12	0.00	0.00	0.95	4.12	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	1.85	10.76	4.61	0.00	0.62	0.31	3.38	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	4.17	5.77	1.28	0.00	0.96	0.00	2.89	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	2.29	8.03	2.29	0.00	0.76	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	1.97	6.70	3.15	0.00	0.79	0.39	1.58	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	3.03	6.81	2.27	0.00	1.51	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	1.61	1.61	4.01	0.00	0.00	0.80	0.80	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	2.80	9.79	2.80	0.70	0.70	0.70	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	1.00	8.01	0.00	0.00	1.00	1.00	2.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	62.14	12.79	18.28	5.48	14.62	7.31	10.97	7.31	5.48
Cardiac Myocyte, donor2	11605-120I3	6.42	1.98	2.47	0.49	2.47	0.49	0.00	0.49	1.98
Cardiac Myocyte, donor3	11686-122I3	21.47	9.89	7.68	1.47	6.84	3.26	2.63	4.10	1.37
Chondrocyte - de diff, donor1	11261-116G1	132.43	73.49	5.89	3.47	7.63	8.67	27.04	3.47	0.69
Chondrocyte - de diff, donor2	11338-117F6	111.23	35.89	18.48	4.98	14.22	8.88	8.53	6.04	2.13
Chondrocyte - de diff, donor3	11410-118E6	89.89	37.66	9.56	5.35	8.42	7.74	13.65	8.87	3.53
Chondrocyte - re diff, donor2	11339-117F7	66.25	14.32	7.16	1.79	2.69	0.90	3.58	5.37	0.90
Chondrocyte - re diff, donor3	11411-118E7	116.47	23.86	12.94	10.51	14.15	8.49	9.71	10.51	2.83
Ciliary Epithelial Cells, donor1	11242-116D9	15.72	6.54	5.74	5.28	4.71	1.15	1.72	2.64	4.36
Ciliary Epithelial Cells, donor2	11323-117D9	45.53	10.69	7.05	7.70	6.20	3.42	3.21	5.13	5.56
Ciliary Epithelial Cells, donor3	11399-118D4	27.61	6.02	4.34	4.60	5.13	2.48	1.95	4.69	5.66
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	16.32	5.50	14.95	11.10	6.14	2.20	0.46	7.70	4.31
Corneal Epithelial Cells, donor1	11526-119I5	498.43	21.52	34.03	18.22	8.34	30.96	4.83	2.20	1.32
Corneal Epithelial Cells, donor2	11606-120I4	212.73	3.41	23.89	4.55	7.96	5.69	2.28	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	281.70	11.50	20.19	7.41	5.11	13.04	3.58	0.51	1.79
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	23.77	24.93	33.02	5.61	2.97	4.13	5.45	2.81	2.97
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	23.97	27.13	40.06	3.15	4.42	6.31	4.42	2.84	3.78
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	27.61	20.70	10.35	6.90	6.90	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	11.34	20.63	24.62	6.80	1.40	2.38	4.75	1.08	3.78
Dendritic Cells - plasmacytoid, donor1	11228-116C4	38.95	1.37	31.09	1.37	5.81	6.49	0.00	5.12	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	27.42	0.65	35.25	0.00	6.53	5.22	0.00	7.18	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	23.23	1.94	29.52	0.48	3.39	8.23	0.00	5.32	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	55.87	12.01	8.51	0.17	4.17	8.00	4.34	2.67	2.00
Endothelial Cells - Aortic, donor1	11263-116G3	36.38	13.50	3.52	0.00	4.69	6.45	5.87	1.76	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	46.66	23.75	9.33	0.00	5.66	8.20	7.35	0.85	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	27.92	15.73	7.08	0.39	3.54	4.33	3.54	1.57	3.15
Endothelial Cells - Artery, donor1	11264-116G4	63.41	20.36	9.31	0.00	2.33	9.89	7.85	2.04	2.91
Endothelial Cells - Artery, donor2	11341-117F9	42.35	16.94	7.06	0.00	1.88	8.71	6.12	1.18	1.88
Endothelial Cells - Artery, donor3	11413-118E9	33.83	10.52	6.84	0.00	1.75	5.96	4.91	0.70	2.10
Endothelial Cells - Lymphatic, donor1	11236-116D3	24.38	5.10	9.97	0.00	3.32	2.44	1.11	1.77	4.65
Endothelial Cells - Lymphatic, donor2	11317-117D3	14.00	3.65	10.35	0.61	3.04	1.22	1.52	1.83	3.96
Endothelial Cells - Lymphatic, donor3	11393-118C7	12.97	4.23	5.64	0.28	4.23	1.69	0.28	2.54	5.07
Endothelial Cells - Microvascular, donor1	11265-116G5	46.65	8.91	6.54	0.00	5.65	5.35	0.59	1.78	1.78
Endothelial Cells - Microvascular, donor2	11342-117G1	24.99	5.21	8.33	0.00	3.12	4.69	2.08	1.56	2.08
Endothelial Cells - Microvascular, donor3	11414-118F1	21.84	3.97	5.81	0.14	6.52	3.83	1.70	2.27	2.84
Endothelial Cells - Thoracic, donor1	11266-116G6	56.82	23.21	5.60	0.00	4.40	7.20	2.80	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	35.12	11.01	9.43	0.00	2.62	6.29	3.14	2.62	2.62
Endothelial Cells - Umbilical vein, donor1	11243-116E1	34.66	12.42	4.72	0.75	2.86	5.09	3.98	2.24	4.35
Endothelial Cells - Umbilical vein, donor2	11324-117E1	35.20	8.47	4.78	0.22	3.48	4.56	3.04	2.61	3.91
Endothelial Cells - Umbilical vein, donor3	11400-118D5	36.15	10.50	5.01	0.37	1.95	7.69	4.40	2.44	2.44
Endothelial Cells - Vein, donor1	11267-116G7	32.99	15.93	7.96	1.14	4.55	11.38	6.83	3.41	3.41
Endothelial Cells - Vein, donor2	11344-117G3	57.98	18.16	6.99	0.00	4.19	10.48	6.29	1.40	4.89
Endothelial Cells - Vein, donor3	11416-118F3	45.38	17.43	7.85	0.47	4.55	9.73	5.34	1.73	5.02
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	90.76	0.00	26.40	4.95	8.25	11.55	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	49.94	0.00	17.83	0.00	7.13	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	309.56	8.31	31.27	15.88	8.80	17.59	2.69	0.98	4.40
Esophageal Epithelial Cells, donor2	11587-120G3	264.18	6.24	10.40	8.32	8.32	12.48	4.16	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	260.30	0.00	0.00	0.00	0.00	0.00	16.27	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	74.30	30.79	14.37	7.39	16.83	3.28	16.01	13.96	2.05
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.91	6.79	1.97	0.99	1.75	0.33	2.41	0.33	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	14.95	7.58	2.28	0.65	2.28	0.87	3.68	0.22	0.98
Fibroblast - Aortic Adventitial, donor1	11245-116E3	41.60	26.80	11.64	8.73	5.09	4.49	8.13	3.40	1.70
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	85.16	90.34	32.89	4.23	15.97	7.10	26.20	19.79	4.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	29.74	26.37	9.18	3.16	8.33	3.38	8.44	4.96	2.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	137.01	234.24	29.77	3.95	20.29	12.38	66.93	29.77	3.16
Fibroblast - Aortic Adventitial, donor3	11401-118D6	51.49	58.80	11.96	5.65	6.64	6.31	14.28	5.65	2.33
Fibroblast - Cardiac, donor1	11268-116G8	48.08	16.78	9.07	4.08	7.71	3.18	7.26	3.18	0.91
Fibroblast - Cardiac, donor2	11345-117G4	9.10	5.31	11.37	9.85	3.79	0.76	3.03	2.27	0.00
Fibroblast - Cardiac, donor3	11417-118F4	94.47	25.39	13.25	11.67	12.46	12.30	8.20	6.15	0.63
Fibroblast - Cardiac, donor4	11452-119A3	38.80	21.52	9.70	3.33	6.67	5.46	4.24	4.85	3.33
Fibroblast - Cardiac, donor5	11456-119A7	24.62	11.93	7.49	4.31	3.93	2.66	5.46	3.17	1.65
Fibroblast - Cardiac, donor6	11460-119B2	23.19	11.82	4.85	4.40	3.94	1.52	3.03	4.09	1.67
Fibroblast - Choroid Plexus, donor1	11492-119E7	36.45	8.44	13.94	8.04	10.05	3.48	1.47	9.38	5.36
Fibroblast - Choroid Plexus, donor2	11572-120E6	49.61	8.63	15.10	15.10	8.63	5.18	1.73	10.35	7.33
Fibroblast - Choroid Plexus, donor3	11653-122E6	4.39	4.39	4.39	2.93	1.46	1.46	5.86	7.32	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	40.36	32.75	4.61	6.46	5.07	4.84	6.00	2.77	2.77
Fibroblast - Conjunctival, donor3	11692-122I9	38.50	17.81	14.59	3.22	12.55	3.73	4.58	10.01	7.12
Fibroblast - Dermal, donor1	11269-116G9	23.95	45.78	12.68	2.11	6.10	3.05	15.03	3.52	2.11
Fibroblast - Dermal, donor2	11346-117G5	75.47	29.72	7.08	5.19	2.83	11.79	5.66	2.36	1.89
Fibroblast - Dermal, donor3	11418-118F5	25.39	68.42	14.26	2.90	7.01	1.93	18.13	5.68	4.59
Fibroblast - Dermal, donor4	11450-119A1	56.86	26.68	4.97	5.09	2.03	12.32	9.95	1.92	1.70
Fibroblast - Dermal, donor5	11454-119A5	54.08	36.11	4.36	5.58	2.79	8.55	10.99	1.92	1.05
Fibroblast - Dermal, donor6	11458-119A9	57.66	42.72	5.68	9.10	3.57	10.72	10.72	2.76	1.30
Fibroblast - Gingival, donor1	11237-116D4	171.37	40.40	18.12	15.20	11.04	14.16	11.87	6.66	3.96
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	118.95	53.19	16.51	11.27	11.00	9.17	13.89	10.22	2.10
Fibroblast - Gingival, donor2	11318-117D4	131.26	43.88	12.39	9.75	6.46	17.53	16.08	3.95	3.69
Fibroblast - Gingival, donor3	11394-118C8	148.41	43.22	19.24	11.99	9.96	10.54	13.73	7.06	5.12
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	20.78	47.79	12.47	12.47	7.27	1.04	11.43	2.08	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	38.76	39.82	12.51	17.80	10.57	2.82	14.80	4.76	2.11
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	72.18	26.50	12.47	12.94	6.08	8.26	8.73	3.59	2.81
Fibroblast - Gingival, donor6 (control)	11922-125H5	84.65	34.35	11.49	11.90	7.98	7.44	15.01	5.54	2.30
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	58.93	50.46	6.70	20.82	5.65	5.29	11.29	4.59	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	131.18	28.52	9.21	13.45	9.21	8.34	10.97	7.02	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	116.72	24.13	9.41	27.27	10.09	5.45	11.04	5.73	2.32
Fibroblast - Gingival, donor8 (control)	11926-125H9	90.06	33.90	8.99	18.98	5.92	6.69	13.93	6.03	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	73.66	44.02	20.40	12.91	11.45	5.87	13.35	10.71	5.58
Fibroblast - Lung, donor1	11270-116H1	85.64	23.11	9.52	4.08	13.59	19.03	5.44	9.52	6.80
Fibroblast - Lung, donor2	11347-117G6	37.30	37.30	20.89	7.46	7.46	10.45	7.46	8.95	4.48
Fibroblast - Lung, donor3	11419-118F6	39.46	28.28	7.81	6.75	11.40	3.80	8.86	5.49	4.64
Fibroblast - Lymphatic, donor1	11506-119G3	145.78	122.45	18.33	14.99	9.16	18.33	12.50	5.83	5.83
Fibroblast - Lymphatic, donor2	11586-120G2	58.74	37.76	6.99	8.39	13.99	2.80	13.99	4.20	9.79
Fibroblast - Lymphatic, donor3	11667-122G2	92.92	36.38	14.55	15.67	10.64	15.11	10.08	3.36	2.52
Fibroblast - Mammary, donor1	11540-120B1	83.63	77.54	19.49	3.65	14.21	10.56	15.83	6.90	2.44
Fibroblast - Mammary, donor2	11620-122A9	99.86	43.94	19.97	11.98	15.98	11.98	15.98	7.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	77.43	71.48	17.87	0.00	17.87	5.96	11.91	11.91	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	112.31	36.85	10.47	9.12	6.40	10.09	9.50	4.46	3.10
Fibroblast - Periodontal Ligament, donor2	11319-117D5	123.47	50.66	11.22	10.16	6.83	20.48	16.23	6.07	2.73
Fibroblast - Periodontal Ligament, donor3	11395-118C9	173.49	44.06	10.10	18.67	6.43	12.85	14.99	5.51	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	58.01	32.82	11.83	7.63	4.96	9.16	12.98	8.01	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	75.33	24.84	9.72	7.83	16.20	9.18	11.34	6.75	2.16
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	36.18	34.79	10.44	9.97	15.66	2.78	14.96	9.86	2.55
Fibroblast - Pulmonary Artery, donor1	11250-116E8	20.78	9.73	6.30	3.32	3.21	2.21	2.10	1.77	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	57.91	33.73	19.30	19.91	8.13	5.89	7.52	4.47	2.44
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	82.86	44.10	20.05	13.36	8.02	10.02	11.36	6.68	4.01
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	42.30	24.51	15.02	4.35	6.72	5.14	3.95	4.74	4.74
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	405.23	208.37	34.13	23.62	23.81	36.91	77.59	17.66	4.76
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	52.04	23.09	9.95	11.90	10.30	3.55	4.80	5.51	1.78
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	45.92	34.69	12.81	3.35	6.90	3.74	6.50	3.55	1.58
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	299.05	163.97	28.58	8.42	13.24	33.09	57.16	19.56	4.21
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	73.41	46.53	10.15	1.51	7.88	7.12	8.74	4.97	2.70
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	312.29	132.86	37.46	9.11	31.13	28.34	49.10	36.19	9.62
Fibroblast - skin normal, donor1	11553-120C5	84.83	42.17	14.44	3.94	13.29	6.07	7.88	8.04	5.09
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	166.02	222.56	45.92	9.62	19.45	16.64	67.97	23.66	8.02
Fibroblast - skin normal, donor2	11561-120D4	29.74	40.69	11.35	1.61	6.33	2.41	8.54	4.52	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	161.70	208.54	46.54	11.49	24.48	19.04	66.79	24.48	8.46
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	24.19	32.81	11.68	3.89	11.76	1.57	7.95	6.38	3.07
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	34.19	43.08	13.16	2.56	10.26	3.59	9.57	5.30	7.01
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	148.12	107.40	21.68	4.93	14.78	19.71	35.80	19.71	7.55
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	48.36	31.64	9.37	3.20	6.39	4.26	7.67	4.58	1.81
Fibroblast - skin walker warburg, donor1	11554-120C6	73.21	37.28	15.35	6.24	8.27	7.08	9.61	3.04	1.69
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9.41	3.29	2.35	1.25	2.98	1.41	0.78	0.47	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	93.25	0.87	13.94	3.49	8.72	4.36	0.87	6.10	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	234.03	3.81	14.39	10.05	9.19	9.88	2.08	0.87	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	201.17	5.47	15.09	20.30	9.37	14.31	1.82	0.52	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	283.11	7.41	12.26	22.74	7.67	16.61	2.30	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	5.36	0.00	1.53	2.30	2.30	0.00	0.00	0.77	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	7.66	0.64	0.00	2.55	1.28	0.00	0.00	1.28	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	3.14	0.00	1.14	1.43	0.57	2.00	0.00	0.00	7.42
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1.65	0.00	0.28	2.21	0.28	0.00	0.28	0.00	6.34
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	0.91	0.23	1.60	4.34	0.23	0.00	0.00	0.00	8.90
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	1.39	0.59	0.59	1.98	0.59	0.99	0.20	0.59	7.93
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1.32	0.26	0.26	0.00	0.00	0.00	0.00	0.00	5.55
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	1.63	0.33	1.96	4.57	0.33	0.00	0.00	0.33	7.50
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	1.33	1.33	1.33	1.33	0.88	0.00	0.00	0.00	3.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	1.98	0.85	1.55	0.85	0.42	0.99	0.00	0.28	2.83
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	3.20	1.60	2.59	1.72	1.23	0.86	0.25	0.37	4.56
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	3.49	0.27	1.61	1.34	1.07	1.88	0.54	0.54	4.03
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	12.27	6.07	4.09	1.36	1.86	3.35	0.74	0.62	2.60
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	16.61	10.52	3.05	2.08	2.21	7.75	1.38	0.42	2.91
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	20.53	6.51	3.46	1.83	1.83	4.68	2.03	0.61	4.07
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	6.62	3.19	5.93	1.37	1.83	0.46	1.14	2.05	6.85
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	8.10	7.60	4.86	1.74	1.62	2.49	1.37	0.62	3.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	20.98	8.09	7.65	1.53	2.19	3.93	1.31	1.97	8.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	2.95	2.07	6.21	2.07	0.59	0.00	0.00	0.30	5.61
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	3.02	2.38	3.50	1.27	0.95	0.64	0.16	0.48	2.70
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	5.36	2.68	5.14	0.45	0.89	0.67	0.22	1.34	7.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	1.21	3.23	3.83	1.41	0.40	0.40	2.22	0.20	6.25
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	2.71	3.56	3.73	1.36	0.17	0.34	1.19	0.34	3.05
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	7.27	4.61	7.09	2.39	2.04	0.71	0.98	0.62	5.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	1.25	2.08	6.87	1.14	0.83	0.21	0.42	0.83	6.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	0.85	2.56	7.51	1.54	1.02	0.17	0.17	0.51	4.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	1.66	1.88	5.75	1.44	0.66	0.33	0.55	0.33	3.43
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	5.99	2.66	6.24	1.66	1.75	0.58	0.92	1.08	5.74
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	3.27	2.25	6.74	1.43	2.04	1.02	0.00	0.82	2.86
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	1.65	3.71	6.81	1.44	1.65	0.00	1.65	1.03	7.22
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	0.92	2.65	6.92	1.38	0.69	0.12	0.46	0.58	2.88
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	2.00	3.84	6.84	1.17	0.83	0.33	1.17	0.83	7.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	0.44	2.65	7.49	0.66	0.88	0.00	0.66	0.22	4.41
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	0.98	3.32	8.24	1.72	0.86	0.49	0.74	0.37	4.55
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	4.05	4.05	6.97	1.95	1.30	0.81	0.65	1.30	5.35
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	1.28	2.25	10.26	1.60	1.28	0.32	0.96	0.00	8.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	1.33	4.17	7.30	1.14	0.85	0.38	1.14	0.76	3.51
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	0.63	2.69	6.33	0.95	0.79	0.32	0.63	0.32	5.69
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	0.91	3.95	10.34	1.22	1.22	0.00	2.13	1.22	3.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	2.20	6.59	6.06	1.46	1.25	0.84	2.51	0.63	3.45
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	1.54	3.73	7.90	0.44	1.32	0.44	0.66	1.54	3.95
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	0.84	5.33	8.98	0.84	1.96	0.56	1.12	2.24	4.21
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	5.37	7.31	9.35	1.20	1.76	0.93	2.04	2.13	2.31
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	1.34	4.55	9.09	2.41	1.60	0.00	1.60	0.27	2.67
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	7.04	12.39	12.70	1.84	2.14	1.68	3.98	0.77	4.59
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	4.66	7.25	9.07	1.42	1.94	0.65	2.33	1.94	2.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	0.81	3.52	8.40	1.36	0.54	0.00	0.54	1.36	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	8.85	6.08	12.72	2.03	2.58	0.55	1.66	1.66	4.61
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	6.58	7.90	18.42	2.19	6.80	0.88	3.73	3.95	7.02
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	1.98	2.98	13.88	0.99	0.99	0.00	0.00	0.00	5.95
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	14.51	17.68	17.41	6.20	8.05	1.45	6.86	4.75	4.62
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	21.59	23.20	23.61	5.65	10.09	1.41	7.47	5.25	7.87
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	3.30	5.59	6.61	0.76	0.76	0.00	0.51	1.02	3.56
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	1.79	0.20	1.19	2.39	0.20	0.80	0.00	0.40	4.98
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	1.69	1.08	0.92	2.16	0.31	0.31	0.00	0.62	4.16
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1.23	0.41	0.82	1.02	0.61	0.41	0.00	0.20	5.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	2.82	0.00	0.63	1.88	1.25	0.31	0.00	0.00	3.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	2.26	0.00	0.85	0.85	0.57	0.28	0.00	0.00	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	2.31	0.00	0.46	1.84	0.92	1.84	0.00	0.00	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2.47	0.00	0.00	2.47	0.00	0.00	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	4.25	0.39	0.00	0.39	0.39	1.55	0.00	0.00	3.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	3.21	0.00	0.00	8.02	1.60	1.60	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	0.00	1.74	3.48	0.00	3.48	0.00	0.00	13.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	3.25	0.00	0.98	1.63	0.65	0.65	0.00	0.00	3.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	2.88	0.00	1.24	1.65	1.65	0.41	0.00	0.41	4.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	0.00	0.00	0.00	0.00	3.33	0.00	0.00	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	3.08	0.00	0.00	1.40	0.28	0.84	0.00	0.00	3.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	3.60	0.00	0.33	0.65	1.31	0.98	0.00	0.33	3.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	1.68	0.00	0.00	2.52	1.68	0.84	0.00	0.00	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1.91	0.00	1.27	0.95	1.59	1.27	0.00	0.00	4.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	1.02	0.00	1.02	1.02	1.36	0.68	0.00	0.00	4.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	2.09	0.00	0.00	6.26	0.00	0.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	5.15	0.00	0.57	0.57	2.29	1.72	0.00	0.57	5.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	4.44	0.00	0.30	0.89	1.78	0.00	0.00	0.30	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	5.08	0.00	5.08	1.69	0.00	0.00	0.00	1.69	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	3.31	0.00	1.24	1.66	1.24	1.24	0.00	0.00	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	0.69	0.46	0.46	0.69	0.46	0.69	0.00	0.00	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	3.84	0.00	0.38	1.92	2.69	1.54	0.00	0.00	5.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	5.54	0.00	2.28	2.61	0.65	1.96	0.00	0.33	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	9.36	0.67	3.34	1.34	0.67	0.00	0.00	0.67	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	3.47	0.00	1.54	1.93	0.77	0.77	0.00	0.39	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	7.87	0.34	1.03	2.74	1.71	0.68	0.00	0.34	5.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	2.48	0.00	4.97	0.00	2.48	0.00	0.00	0.00	9.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	3.30	0.00	2.36	1.89	0.47	1.42	0.00	1.42	5.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	1.81	0.00	4.22	1.21	1.21	1.21	0.00	0.60	6.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	3.05	0.00	3.05	2.54	2.54	1.02	0.00	0.51	9.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	2.39	0.00	3.19	3.19	0.40	0.40	0.00	0.80	7.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	2.96	0.00	2.47	2.47	0.00	1.48	0.49	0.00	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	4.72	0.00	4.72	2.36	3.54	1.18	1.18	3.54	8.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	4.08	0.58	2.33	2.33	2.92	1.75	0.00	0.00	7.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	1.32	0.00	3.07	1.32	1.76	1.76	0.00	0.00	5.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	0.00	0.85	3.39	2.54	1.70	0.85	0.00	0.85	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	4.78	1.19	0.00	1.19	1.79	0.60	0.00	0.60	5.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	4.37	0.00	1.46	1.94	1.46	1.46	0.00	0.49	3.40
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	108.42	4.57	10.27	7.99	5.71	9.13	4.57	6.85	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	150.94	23.29	7.48	16.22	11.64	9.98	12.89	7.07	3.74
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	109.07	28.11	12.37	13.49	11.24	15.74	12.37	4.50	4.50
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	117.35	12.69	11.10	10.47	14.27	9.83	5.71	7.61	2.54
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	162.92	22.56	12.53	7.52	10.44	7.10	5.01	5.01	4.60
Hep-2 cells mock treated, biol_rep1	11898-125E8	26.81	4.29	4.06	16.36	0.70	2.09	1.97	0.46	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	28.87	5.57	4.73	20.59	1.52	2.19	0.68	0.68	1.35
Hep-2 cells mock treated, biol_rep3	11900-125F1	34.13	3.19	6.37	22.52	1.59	1.82	2.05	0.23	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	31.70	4.81	5.14	17.71	1.64	2.51	1.42	0.33	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	31.59	6.02	5.59	21.06	1.72	3.01	1.07	1.29	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	31.22	4.95	4.74	18.51	0.43	1.94	1.51	0.00	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	19.68	3.86	4.86	11.83	0.50	1.49	0.87	0.12	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	21.10	3.09	3.60	13.04	1.20	1.37	1.20	0.69	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	23.71	2.88	3.52	8.97	0.32	3.20	1.60	0.32	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	39.73	4.48	8.39	1.68	1.68	13.43	1.12	2.24	5.04
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	43.28	17.74	12.12	11.69	4.33	6.92	5.19	1.73	2.60
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	26.44	2.64	7.93	0.00	2.64	2.64	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	97.00	17.99	18.34	5.64	7.05	8.82	4.23	10.58	3.17
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	100.26	21.07	15.98	9.44	16.71	8.72	5.81	10.90	6.54
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	35.14	8.92	4.02	7.69	1.57	5.07	3.50	1.92	1.40
Hepatocyte, donor1	11523-119I2	2.42	0.00	3.63	9.68	14.53	0.00	0.00	8.47	3.63
Hepatocyte, donor2	11603-120I1	2.15	0.00	3.23	14.01	5.39	0.00	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	6.75	0.61	1.84	17.79	7.98	0.61	0.00	1.84	2.45
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.65	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	31.46	0.00	6.82	4.37	3.32	1.92	0.00	0.17	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	16.46	6.59	3.29	3.84	3.70	2.47	1.10	2.47	1.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	31.84	15.92	3.18	3.18	6.37	0.00	3.18	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	13.35	20.03	0.00	6.68	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	54.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	15.23	24.92	9.69	9.69	0.00	11.08	1.38	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	12.51	0.00	7.51	5.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	23.74	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	33.32	17.94	15.38	23.07	5.13	2.56	5.13	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	4.57	0.00	18.28	0.00	4.57	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	38.98	27.61	29.24	16.24	0.00	9.75	3.25	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	21.67	13.34	13.34	0.00	5.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	3.63	10.89	7.26	3.63	7.26	0.00	7.26	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	31.76	31.76	18.53	22.50	2.65	3.97	3.97	1.32	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	14.41	21.06	4.43	8.87	4.43	4.43	4.43	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	5.24	15.71	10.48	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	11.34	15.12	7.56	7.56	3.78	5.04	3.15	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	23.20	12.37	6.19	12.37	4.64	13.92	1.55	4.64	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	29.27	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	22.61	25.84	15.50	19.38	2.58	3.88	1.94	1.29	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	24.15	24.15	11.27	16.10	0.00	6.44	6.44	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	11.95	11.95	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	25.26	26.08	13.04	17.93	2.44	8.15	4.07	2.44	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	31.07	26.03	19.73	18.47	5.88	6.72	2.52	2.52	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	0.00	0.00	0.00	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	18.48	20.90	14.47	12.06	2.41	11.25	3.21	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	21.24	17.54	7.39	10.16	0.00	6.46	2.77	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	30.16	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	13.22	10.38	6.14	7.55	0.94	5.19	0.94	1.89	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	19.95	17.23	10.88	9.98	2.72	4.53	2.72	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	29.48	0.00	0.00	0.00	0.00	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	11.84	30.13	16.14	20.45	4.30	6.46	5.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	22.87	13.98	11.43	10.16	2.54	10.16	6.35	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	16.43	16.43	0.00	0.00	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	17.86	26.78	17.86	15.94	5.74	8.29	8.29	1.28	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	27.34	40.10	9.11	20.05	1.82	5.47	5.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	15.80	47.41	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	32.85	32.13	15.71	18.57	6.43	13.57	9.28	0.71	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	19.91	13.27	23.23	3.32	6.64	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.66	15.74	8.33	9.88	2.78	5.86	2.16	1.23	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	38.63	43.90	12.29	19.32	0.00	10.54	8.78	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	34.57	6.29	18.86	3.14	12.57	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	27.12	36.86	10.43	15.99	2.78	11.13	7.65	1.39	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	35.41	15.49	6.64	4.43	8.85	0.00	0.00	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	12.97	16.21	6.48	3.24	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	18.31	18.31	6.10	11.34	2.62	8.72	1.74	2.62	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	31.50	20.25	9.00	11.25	0.00	9.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	0.00	0.00	10.45	0.00	6.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	29.87	22.40	10.67	9.60	2.13	5.33	0.00	3.20	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	36.02	15.24	11.08	23.55	0.00	6.93	1.39	2.77	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	48.44	25.65	14.25	17.10	0.00	19.95	0.00	2.85	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	24.85	14.73	11.97	13.81	0.92	5.52	3.68	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	3.03	9.08	6.05	0.00	9.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	6.21	6.21	6.21	6.21	6.21	6.21	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	11.63	4.23	11.63	1.06	5.29	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	348.43	17.63	31.42	4.41	12.40	15.67	5.96	1.96	0.00
Keratinocyte - epidermal, donor2	11349-117G8	291.06	13.47	11.71	15.81	7.03	18.15	0.00	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	345.87	12.12	12.59	2.93	5.87	17.80	5.87	0.66	0.00
Keratinocyte - oral, donor1	11251-116E9	237.71	8.51	24.63	12.03	6.58	14.64	2.04	2.04	2.95
Keratocytes, donor1	11527-119I6	63.26	47.10	14.10	18.57	3.44	5.16	8.25	4.81	0.69
Keratocytes, donor2	11607-120I5	169.91	51.56	11.72	17.58	8.20	16.41	14.06	0.00	2.34
Keratocytes, donor3	11688-122I5	38.33	29.84	7.31	8.89	4.54	1.98	9.29	5.14	6.32
Krukenberg tumor cell line:HSKTC	10687-109F3	193.42	8.79	32.97	10.99	32.97	8.79	2.20	8.79	0.00
Lens Epithelial Cells, donor1	11529-119I8	15.10	3.24	4.31	2.16	2.16	2.16	6.47	2.16	3.24
Lens Epithelial Cells, donor2	11609-120I7	7.61	2.31	5.07	7.15	2.54	0.81	0.23	1.61	4.61
Lens Epithelial Cells, donor3	11690-122I7	42.08	8.07	9.08	8.07	6.46	3.94	1.82	3.73	1.92
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	10.55	2.96	4.15	0.36	0.95	2.02	0.71	0.71	2.25
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	10.88	1.95	1.67	0.00	0.84	1.95	0.28	0.56	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8.50	1.42	1.89	0.31	1.89	2.05	0.94	0.16	1.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	7.53	1.08	2.15	1.61	1.08	1.61	0.00	0.54	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	14.50	1.58	2.52	0.32	0.95	2.52	1.26	1.26	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.63	1.19	2.26	0.32	1.40	1.40	0.65	0.43	1.94
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.57	2.46	3.69	0.41	0.41	1.23	0.82	1.23	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	13.91	3.54	2.02	0.00	1.52	2.28	0.25	0.00	3.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.45	1.97	1.97	0.14	1.27	1.13	0.70	0.84	1.27
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	12.66	1.58	2.77	0.00	1.19	0.79	0.40	0.40	1.98
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.60	2.13	3.49	0.19	0.58	0.58	0.39	0.39	1.94
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.59	1.30	2.22	0.00	1.85	1.11	0.19	0.56	2.22
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.76	0.70	3.14	1.05	2.09	0.35	1.05	0.00	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	9.54	0.48	2.86	0.95	1.67	1.43	0.95	0.72	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.77	1.92	2.06	0.41	1.10	1.10	0.00	0.55	2.33
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.85	1.85	1.54	1.54	0.00	1.23	0.31	0.31	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	11.22	1.56	2.18	0.00	0.94	1.25	0.94	0.94	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.97	1.28	2.38	0.00	1.28	0.73	0.73	1.10	2.38
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	11.85	1.65	1.65	0.33	0.99	1.32	0.33	0.33	2.63
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	14.35	1.76	2.64	0.29	1.17	1.17	0.29	0.88	1.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	12.20	3.98	3.24	0.00	0.75	1.24	1.49	0.50	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.24	2.91	1.94	0.00	0.48	2.42	1.94	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	12.12	1.62	1.62	0.54	1.35	0.54	0.54	1.35	2.96
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.27	1.82	1.97	0.15	1.36	1.36	0.76	0.45	1.82
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.78	1.56	1.56	0.52	1.04	0.00	1.56	0.52	2.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	12.98	0.84	2.72	0.21	1.26	2.09	0.42	0.42	1.68
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	10.83	1.95	2.41	0.45	1.50	1.50	1.20	0.60	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	10.32	0.69	2.75	0.00	0.00	1.38	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	12.98	1.32	2.63	0.56	1.69	1.51	0.75	0.00	2.63
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.95	1.48	2.65	0.53	1.38	0.85	0.85	0.74	1.59
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	5.81	0.48	2.91	0.48	0.48	0.97	0.48	0.48	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	13.89	1.98	4.30	0.00	0.66	1.32	0.66	0.66	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.19	1.61	2.35	0.50	0.99	0.87	0.50	0.50	1.98
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	5.92	0.37	3.70	0.74	1.11	1.85	1.11	0.00	2.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	11.12	0.99	1.98	0.49	0.49	0.74	0.00	0.25	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.84	1.65	2.47	0.00	0.69	1.65	0.69	0.55	1.79
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	12.22	0.64	1.61	0.64	0.96	1.29	0.64	0.64	1.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	11.26	1.22	3.65	0.30	1.22	3.65	0.00	0.30	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.80	0.98	2.80	0.14	0.98	1.12	0.70	0.28	1.96
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	8.18	3.91	1.42	0.36	0.36	0.36	0.36	0.36	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	14.54	1.94	4.36	0.97	0.48	0.48	0.97	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.94	2.18	2.02	0.62	0.78	0.78	0.47	0.47	1.87
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	7.52	1.43	1.43	0.00	0.72	1.07	0.72	0.36	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	24.50	4.25	3.92	0.33	2.29	3.92	0.00	0.33	2.61
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.47	1.65	0.94	0.00	1.88	0.47	0.47	0.00	2.83
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	13.86	1.61	5.45	0.62	1.24	1.24	0.74	0.12	3.22
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	18.19	1.28	1.54	0.00	0.51	1.28	0.77	0.51	3.07
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.56	1.19	2.39	0.30	1.79	0.00	0.30	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	0.00	33.99	22.66	13.60	0.00	0.00	2.27	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	2.30	1.53	27.62	13.04	14.58	0.77	3.07	6.14	9.97
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	4.45	0.74	23.01	14.84	11.88	0.00	0.00	4.45	12.62
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	7.19	2.96	35.12	24.12	11.85	0.00	0.85	5.08	16.50
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.03	1.41	22.51	26.02	11.25	2.11	0.00	2.11	12.66
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	0.00	1.87	20.55	26.15	4.67	0.00	0.00	3.74	7.47
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	4.64	1.55	18.03	18.03	11.34	0.00	0.52	5.15	11.85
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	2.38	0.00	21.41	15.46	13.08	0.00	0.00	7.14	7.14
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	3.62	1.36	28.95	26.69	11.08	0.23	0.00	4.52	16.51
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	1.45	0.58	17.45	13.67	6.40	0.00	0.29	2.62	8.72
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	2.70	0.90	13.06	17.11	4.95	1.80	0.45	3.60	7.20
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	6.23	1.08	37.12	33.06	12.74	0.14	0.14	4.06	16.94
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	4.62	1.54	32.35	24.14	15.41	0.51	0.00	3.59	16.43
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	1.41	0.35	15.53	13.06	7.76	0.35	0.00	2.47	10.23
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	2.00	0.67	16.66	10.66	3.33	0.00	0.00	0.67	11.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	5.09	1.02	31.58	20.88	11.72	0.00	0.00	5.09	11.72
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	5.87	0.80	19.21	19.74	7.20	0.00	0.27	1.87	10.14
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	3.21	0.57	19.84	17.76	6.42	0.00	0.19	3.78	11.71
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	4.29	1.23	31.29	20.25	10.43	0.00	0.61	3.68	14.11
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	8.97	2.45	33.43	28.54	12.23	0.00	0.82	2.45	7.34
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	4.58	1.46	21.45	15.83	7.71	0.42	0.21	3.54	11.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	3.64	1.96	17.38	17.10	7.57	0.00	0.00	2.24	9.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	5.15	2.06	35.03	16.49	8.24	0.00	0.00	5.15	16.49
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	3.48	2.61	23.80	20.61	8.42	0.00	0.87	2.90	11.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	4.48	0.30	17.94	15.84	7.17	0.60	0.30	2.09	6.88
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1.66	1.66	16.60	14.94	3.87	0.00	0.55	3.32	9.96
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	7.07	1.41	35.70	33.93	10.96	0.00	1.06	6.01	24.39
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	4.43	1.48	23.97	19.18	5.16	0.74	0.37	3.69	9.59
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	9.21	24.18	20.72	10.36	0.00	0.00	3.45	10.36
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	6.52	1.92	29.55	24.56	11.13	0.77	0.77	3.07	17.27
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	8.49	2.83	27.74	25.48	9.62	0.57	0.00	2.83	10.19
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	4.10	4.10	15.59	18.05	9.85	0.00	0.00	4.10	9.03
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	8.59	0.90	41.57	26.21	12.65	0.90	0.45	6.33	14.91
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	4.31	1.44	25.14	16.52	10.05	0.00	1.44	2.15	9.34
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.22	2.99	18.67	12.70	7.47	0.00	0.00	2.24	8.22
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	7.43	1.86	30.47	25.64	14.86	1.11	1.11	5.57	12.26
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	8.18	0.43	24.12	9.05	9.48	0.86	1.29	0.86	8.61
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	9.42	1.71	24.83	11.13	8.56	0.86	1.71	0.86	10.28
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	5.66	0.67	26.65	19.32	10.00	1.00	0.00	5.33	10.99
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6.03	1.21	25.94	18.10	9.65	0.00	0.00	1.81	10.86
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.24	2.84	27.02	7.82	10.66	0.00	0.00	2.84	5.69
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	4.47	1.37	27.84	18.22	12.03	0.34	0.34	3.78	9.97
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.98	1.07	25.76	8.59	5.90	0.00	2.15	4.29	6.98
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	4.71	2.02	26.93	13.47	4.71	0.67	0.00	3.37	8.08
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	5.56	3.33	28.52	14.08	7.04	0.37	0.37	4.44	14.45
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	9.30	2.33	24.42	8.14	6.98	0.00	0.00	3.49	10.47
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	2.12	1.06	31.73	9.52	9.52	0.00	1.06	3.17	9.52
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	8.80	1.60	31.21	15.61	10.00	0.00	0.00	4.80	11.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	1.45	2.18	41.43	28.35	14.54	0.00	0.73	6.54	10.90
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	8.43	0.77	29.13	31.43	17.63	0.77	0.77	3.07	17.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	4.93	0.99	31.57	31.08	14.80	0.00	0.00	4.93	17.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	5.65	1.88	40.46	22.58	9.41	0.00	0.00	5.65	13.17
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	4.53	1.51	41.23	31.17	9.55	0.50	0.50	7.04	23.13
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	5.86	1.35	31.99	31.09	7.66	0.00	0.00	4.96	18.48
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	10.33	0.00	30.98	37.86	5.16	0.00	1.72	1.72	8.61
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	6.23	1.78	25.83	28.50	10.24	0.00	0.00	4.90	12.02
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.60	0.39	32.85	29.72	12.90	0.39	1.17	3.13	19.94
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.28	3.96	27.05	23.75	11.22	0.66	0.00	3.30	10.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	6.23	2.59	30.62	30.10	10.90	1.04	0.00	4.15	13.49
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	4.38	2.63	29.75	37.63	14.88	0.44	0.00	5.25	22.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	3.35	1.68	25.72	24.60	9.50	0.00	0.00	3.91	12.30
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	4.42	1.77	39.31	24.29	10.16	0.44	0.88	3.53	11.92
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	5.40	1.54	29.31	23.14	13.11	0.77	0.00	3.47	11.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	7.09	2.03	23.29	21.77	9.62	0.00	0.00	3.54	10.63
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	6.25	1.44	31.72	21.63	13.94	1.44	1.44	5.29	6.25
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	8.35	1.59	24.65	19.48	9.14	0.00	0.80	6.36	15.90
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	6.08	3.65	33.42	13.37	7.90	0.00	0.61	3.65	9.72
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	5.53	1.38	13.83	9.68	5.53	0.00	0.00	0.69	8.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	8.36	3.42	29.26	23.18	9.12	0.38	1.14	2.66	15.96
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	11.88	1.55	29.44	22.21	6.71	1.03	0.00	0.52	11.88
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.88	1.81	18.74	9.07	9.07	1.21	0.60	3.02	7.26
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	8.87	2.54	25.99	17.43	8.56	1.27	0.63	5.07	13.31
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	18.66	2.67	39.45	18.66	12.79	1.07	1.60	3.73	9.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.77	5.75	22.41	16.09	6.32	0.00	1.15	2.30	5.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	19.03	2.57	35.48	21.08	11.31	3.09	0.51	9.26	13.37
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	21.22	4.24	38.20	19.10	11.32	0.71	0.00	0.71	8.49
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.35	2.27	23.27	14.19	7.94	1.13	0.00	2.84	6.81
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.15	3.33	36.19	24.96	11.23	0.00	1.25	2.50	13.31
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	12.53	3.92	33.67	13.31	7.05	0.78	0.00	3.13	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	9.60	3.76	25.47	11.69	4.18	1.25	0.84	2.09	3.76
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	10.69	3.25	29.27	20.91	9.76	0.93	1.86	3.25	12.55
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	14.05	6.02	28.77	14.72	8.03	0.00	2.01	2.01	6.69
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	15.50	2.67	25.66	10.16	8.55	0.53	1.07	3.21	3.21
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	13.74	2.02	33.94	16.16	5.25	1.62	1.62	2.83	14.95
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	14.68	4.59	35.79	11.93	7.34	2.75	0.00	1.84	9.18
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	13.34	3.56	21.34	4.45	5.33	0.00	0.00	0.89	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	16.53	5.13	31.91	14.25	12.54	0.57	1.14	5.13	6.27
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.10	3.83	29.14	6.90	7.67	0.00	1.53	2.30	9.20
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	13.68	2.74	22.98	3.83	3.28	0.55	0.55	2.74	3.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	11.58	3.56	40.09	9.80	9.35	0.89	1.34	2.67	8.91
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	16.38	2.08	52.77	11.70	10.66	0.52	1.30	4.16	13.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	8.62	2.65	24.53	5.97	7.96	1.33	0.66	3.98	4.64
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	0.00	33.26	8.31	10.39	2.08	0.00	4.16	6.24
Macrophage - monocyte derived, donor1	11232-116C8	55.16	12.76	23.48	1.14	0.91	5.24	3.19	3.19	3.87
Macrophage - monocyte derived, donor2	11313-117C8	13.40	27.89	19.64	5.32	0.55	2.39	4.95	1.28	0.73
Macrophage - monocyte derived, donor3	11389-118C3	40.50	23.99	25.43	6.82	1.44	8.52	7.60	2.88	3.41
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	106.74	4.78	6.37	10.09	1.59	9.03	1.06	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	193.95	2.06	15.85	12.20	6.18	10.77	0.63	0.00	0.32
Mallassez-derived cells, donor3	11930-125I4	127.03	4.59	13.62	9.59	3.20	11.95	0.42	0.28	0.28
Mammary Epithelial Cell, donor1	11273-116H4	296.44	8.17	14.35	7.17	8.07	10.96	1.49	0.70	4.09
Mammary Epithelial Cell, donor2	11350-117G9	261.75	9.27	23.74	5.50	6.66	15.93	3.19	0.58	2.32
Mammary Epithelial Cell, donor3	11422-118F9	385.61	14.47	24.19	14.22	8.98	34.67	4.49	1.50	6.24
Mast cell - stimulated, donor1	11487-119E2	0.00	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.68
Mast cell, donor1	11563-120D6	0.32	0.76	5.62	0.00	0.32	0.00	0.22	0.54	0.32
Mast cell, donor2	11565-120D8	27.93	55.57	19.61	0.00	12.18	8.02	7.13	24.37	1.49
Mast cell, donor3	11566-120D9	36.25	30.17	22.51	0.00	15.53	10.13	4.95	17.11	2.93
Mast cell, donor4	11567-120E1	16.84	41.49	16.67	0.71	14.54	8.16	5.50	19.68	4.61
Mast cell, expanded and stimulated, donor5	11940-126A5	0.55	5.99	7.43	0.00	1.00	0.00	0.89	0.89	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	41.44	65.37	7.00	0.00	6.42	5.84	7.00	7.59	1.75
Mast cell, expanded, donor5	11939-126A4	0.23	0.46	7.34	0.00	0.00	0.00	0.11	0.23	0.34
Mast cell, expanded, donor8	11941-126A6	38.33	24.60	21.42	0.00	20.92	9.54	6.19	38.49	5.52
Melanocyte - dark, donor1	11502-119F8	10.05	1.09	2.98	0.10	2.69	2.59	0.20	0.80	1.99
Melanocyte - dark, donor2	11582-120F7	3.81	2.08	2.42	3.11	3.11	0.69	1.04	2.08	1.38
Melanocyte - dark, donor3	11663-122F7	3.55	8.98	18.91	0.58	0.58	0.29	2.03	0.72	3.26
Melanocyte - light, donor1	11274-116H5	14.10	9.87	21.63	0.47	1.65	3.06	4.00	1.88	2.35
Melanocyte - light, donor2	11351-117H1	2.05	0.68	25.93	0.00	0.00	0.68	0.00	1.36	2.05
Melanocyte - light, donor3	11423-118G1	18.21	5.20	13.01	0.87	1.73	1.73	3.47	2.60	5.20
Melanocyte, donor1 (MC+1)	12641-134G4	23.12	6.77	15.10	0.52	1.56	5.21	2.60	1.87	1.25
Melanocyte, donor2 (MC+2)	12739-135I3	17.75	0.00	16.41	0.00	2.15	2.96	0.00	2.15	2.15
Melanocyte, donor3 (MC+3)	12837-137B2	3.75	0.00	19.02	0.27	0.27	0.00	0.00	0.27	1.61
Meningeal Cells, donor1	11493-119E8	49.50	22.83	10.79	9.55	5.58	4.47	3.72	8.56	3.23
Meningeal Cells, donor2	11573-120E7	10.12	4.40	5.28	4.84	6.60	0.44	0.44	5.72	3.08
Meningeal Cells, donor3	11654-122E7	26.08	6.85	5.62	6.60	4.48	1.14	2.36	3.75	1.55
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	52.47	14.26	9.12	5.13	4.85	3.99	2.28	2.57	3.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	62.39	10.67	4.23	17.21	5.74	2.72	3.62	4.63	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	116.96	78.85	51.25	6.57	23.65	11.83	6.57	26.28	13.14
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	143.90	44.48	15.70	9.16	2.62	19.62	7.85	3.92	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	29.42	33.73	10.05	2.87	2.87	10.76	11.48	2.15	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	11.65	15.67	9.11	16.09	6.35	0.64	3.39	4.24	1.91
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	20.11	13.57	9.55	6.53	3.02	0.00	2.01	3.52	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	123.06	41.09	13.84	8.57	5.49	13.19	9.67	4.83	4.18
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	157.81	35.07	10.23	10.96	4.38	21.19	8.04	4.38	3.65
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	142.20	35.81	9.21	11.66	4.50	15.35	11.66	3.89	5.12
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	82.55	16.21	12.47	4.57	9.28	5.54	3.05	8.45	9.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	46.47	16.36	17.84	25.28	13.38	3.72	4.83	12.27	2.23
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	22.63	9.47	10.79	10.53	6.18	0.79	2.11	4.47	4.21
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	46.88	25.22	9.50	10.68	6.53	3.56	5.04	6.83	1.48
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	49.05	35.03	7.01	2.34	4.67	4.67	0.00	4.67	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	113.99	34.58	10.25	16.01	9.61	15.37	1.92	8.33	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	27.65	24.10	6.03	5.32	2.84	4.25	8.86	0.71	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	16.26	9.07	10.32	11.57	6.25	2.19	2.19	5.94	2.50
Mesenchymal stem cells - umbilical, donor0	11214-116A8	40.64	7.26	7.26	11.61	0.73	7.26	2.18	0.73	2.18
Mesothelial Cells, donor1	11247-116E5	42.16	4.24	7.42	0.53	6.10	4.77	1.33	1.59	2.12
Mesothelial Cells, donor2	12156-128G5	43.04	6.51	6.01	3.00	6.01	5.00	2.00	1.50	2.50
Mesothelial Cells, donor3	11402-118D7	77.61	4.77	6.72	2.02	5.42	6.43	2.38	2.53	1.52
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	40.51	6.75	24.31	0.00	4.05	8.10	5.40	1.35	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	22.41	7.39	13.79	1.23	0.74	3.45	3.45	3.94	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	19.14	14.43	15.02	1.47	0.29	1.47	4.42	2.65	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	58.77	6.91	48.40	0.00	0.00	6.91	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	18.29	7.13	10.54	0.93	0.62	6.51	1.55	0.93	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	11.20	13.90	11.20	2.28	0.41	3.11	6.64	0.62	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	60.22	0.00	34.74	4.63	4.63	9.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	18.77	7.76	13.01	1.75	0.75	3.25	1.25	1.50	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	23.27	21.41	15.83	2.79	1.40	4.65	6.05	1.40	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	58.40	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	15.24	4.27	11.79	1.02	0.00	2.44	2.03	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	19.80	17.03	17.82	1.98	1.98	3.56	4.36	1.19	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	0.00	59.86	0.00	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	8.85	5.31	0.00	0.00	1.77	2.65	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	12.92	12.54	13.68	2.66	1.52	3.42	6.08	1.14	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	21.05	3.95	17.11	0.00	3.95	3.95	1.32	10.53	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	19.31	4.46	8.91	0.85	0.42	5.94	1.06	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.94	13.81	12.89	2.76	0.92	0.92	3.68	4.60	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	16.39	6.56	7.75	1.19	0.30	2.68	1.19	1.49	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	26.83	6.71	16.77	1.68	0.00	5.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	33.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.30	3.26	5.02	0.50	0.25	3.76	0.50	0.75	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.61	12.83	9.03	1.19	0.48	2.38	2.85	1.90	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	24.33	3.87	13.82	0.55	0.00	4.98	1.11	3.87	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	13.58	5.07	6.45	1.61	0.00	2.99	2.07	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	12.62	8.83	10.94	2.52	1.26	2.10	2.94	1.26	1.05
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	21.20	7.34	6.52	1.02	0.82	5.10	2.04	0.61	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	13.30	4.93	7.29	0.43	0.86	4.29	1.93	0.21	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	15.56	8.67	9.34	1.33	0.44	3.11	3.11	0.67	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	10.32	20.64	0.00	0.00	10.32	0.00	20.64	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	16.65	4.82	6.57	0.88	0.22	4.60	1.10	0.88	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	19.77	7.60	11.15	1.01	0.00	3.55	2.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	53.02	4.97	8.28	0.00	3.31	8.28	3.31	3.31	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	23.92	3.26	6.25	1.36	0.54	5.16	0.54	1.90	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	18.53	11.18	8.53	2.65	0.29	4.41	1.47	1.47	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	26.17	3.27	4.36	0.00	0.00	3.27	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	12.97	0.48	5.29	0.96	0.00	2.88	1.44	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	15.61	8.81	7.60	2.40	0.40	2.00	2.80	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	30.17	10.97	8.23	0.00	1.37	4.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	14.52	2.50	2.50	1.50	0.50	2.00	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	26.50	2.04	10.19	2.04	2.04	6.12	2.04	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.89	3.50	2.19	0.44	0.00	3.94	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	20.97	3.31	12.14	3.31	0.00	2.21	4.41	3.31	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	19.21	6.40	5.76	0.00	0.00	3.84	0.00	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	10.66	3.47	1.74	0.00	0.00	3.22	0.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	20.18	6.26	4.18	0.70	0.00	9.74	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	11.05	11.05	0.00	0.00	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	6.15	4.79	2.39	0.00	0.34	4.10	0.34	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.88	7.44	5.69	0.00	0.44	2.19	1.75	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.46	5.68	7.46	0.00	0.00	3.20	1.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	12.62	2.52	4.21	0.00	0.28	2.52	1.68	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.56	5.82	3.74	1.66	0.00	2.91	1.66	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	16.90	8.16	6.99	1.75	0.58	4.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.24	3.02	3.62	0.60	0.00	2.41	1.21	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	9.18	9.60	2.09	1.25	0.00	3.76	1.67	0.83	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	28.88	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	6.46	1.85	2.77	0.92	0.92	1.85	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	10.81	11.38	8.54	0.57	1.14	3.98	1.71	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.56	4.97	4.84	0.55	0.41	1.93	2.07	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	4.92	3.11	2.33	0.78	0.00	1.81	0.26	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.30	10.72	5.15	0.43	0.00	3.86	2.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	9.53	2.54	8.26	1.91	0.00	3.81	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	2.94	1.87	5.34	0.00	0.53	1.33	0.00	0.53	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	12.27	6.88	4.49	2.69	0.00	4.79	2.69	0.90	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.37	2.68	5.23	0.71	0.14	1.13	1.70	0.14	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	4.14	1.91	4.46	0.32	0.32	1.59	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	6.41	9.95	7.08	1.99	0.22	3.76	1.55	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.10	4.17	7.58	0.76	0.00	1.52	2.28	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	4.26	1.99	2.56	0.57	0.00	1.42	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	7.87	8.85	8.36	1.47	0.49	2.21	3.44	0.49	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.12	7.82	14.99	3.26	1.30	5.87	1.30	0.00	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.59	2.94	4.12	1.76	0.00	2.65	1.18	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	8.07	7.21	6.92	4.04	1.15	6.05	6.05	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.95	11.13	5.36	0.41	1.65	5.77	1.24	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	9.53	4.76	9.23	1.79	0.30	5.66	1.49	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	7.53	0.00	0.00	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	3.56	5.35	0.00	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	33.51	4.60	15.77	2.30	0.33	8.21	1.64	0.66	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	33.66	10.52	13.68	3.16	0.00	7.36	1.05	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	47.05	9.69	20.36	1.98	3.56	6.92	2.77	4.15	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.97	6.52	18.63	0.00	1.86	0.00	2.79	1.86	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	33.05	4.13	12.39	0.75	0.38	4.13	2.25	3.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	22.11	9.06	15.45	0.27	1.60	3.73	2.66	1.33	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	48.75	8.60	17.42	1.58	0.79	6.22	1.58	1.92	0.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	3.68	8.10	0.74	0.74	1.47	0.00	2.21	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	30.05	5.50	13.19	1.83	0.00	5.13	1.10	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	23.33	6.22	17.11	3.11	0.00	12.44	0.00	4.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	8.02	1.07	1.07	0.00	0.00	1.60	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	3.86	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	28.28	7.07	8.08	1.01	0.00	2.02	4.04	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	6.32	4.22	2.11	0.00	0.42	1.26	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	0.00	8.17	53.12	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	1.27	0.00	5.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.81	1.62	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	1.51	0.00	16.61	1.51	3.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	154.17	17.13	17.13	1119.19	5.71	11.42	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	3.26	3.26	440.43	0.00	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	4.75	4.75	175.84	0.00	14.26	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	112.94	12.55	12.55	401.57	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	85.10	25.85	10.34	3.23	4.96	6.46	8.40	3.66	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	90.41	13.07	11.50	3.66	11.50	8.88	2.09	7.84	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	18.69	19.36	2.00	1.33	2.67	2.00	9.34	0.67	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	59.68	14.19	5.01	3.34	5.43	3.34	7.10	3.76	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	19.01	17.68	6.85	3.61	1.71	2.28	3.99	1.71	3.99
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	151.61	17.55	25.53	4.79	15.96	12.77	7.98	6.38	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	13.60	14.28	6.80	0.68	5.44	0.00	4.08	4.76	5.44
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	1.84	1.84	0.00	1.84	5.51	5.51	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.12	13.39	3.35	5.44	3.35	0.84	3.77	2.93	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	48.81	26.96	7.90	5.58	8.14	4.18	7.90	4.65	4.88
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.35	12.97	4.05	2.70	3.51	0.00	8.11	3.51	2.16
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	45.83	17.66	8.20	3.78	6.73	4.41	5.26	5.26	2.10
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	11.13	0.00	11.13	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	33.26	22.83	5.46	0.99	4.47	2.48	8.44	5.46	3.97
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	5.95	7.85	5.14	4.33	4.87	0.54	2.71	2.17	2.17
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	44.43	21.08	4.99	3.40	9.29	2.27	9.52	7.48	4.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.94	17.31	3.59	3.27	4.08	0.65	7.84	3.76	3.59
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	48.84	14.22	8.02	5.65	5.47	6.20	3.46	5.65	3.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.79	13.79	3.18	2.65	4.77	0.00	5.30	3.71	4.24
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	31.22	16.21	3.00	4.80	4.80	1.20	5.40	8.40	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	4.59	4.59	5.91	1.97	1.97	0.33	1.97	2.30	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	48.30	20.98	5.69	3.90	11.38	2.93	6.34	7.48	4.55
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	51.50	14.46	5.82	5.82	5.82	6.00	4.59	8.11	2.65
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.25	10.55	1.41	4.92	4.92	1.41	2.11	6.33	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	37.24	18.39	3.68	4.14	9.19	3.22	7.82	5.06	4.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	10.93	15.75	2.25	5.78	7.07	0.00	7.71	4.18	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	25.52	7.24	7.24	5.86	4.83	3.10	4.14	3.45	5.86
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	0.00	0.00	2.53	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	47.23	15.59	5.35	8.47	8.24	2.01	3.34	5.57	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	3.81	8.47	2.12	8.89	4.66	1.69	2.96	4.23	3.39
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	24.45	17.33	5.46	4.51	9.02	2.85	7.36	6.65	3.80
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	12.45	16.74	2.58	7.73	8.16	1.29	7.30	6.01	3.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.66	15.33	4.33	5.33	4.33	0.33	3.67	5.00	2.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	50.05	9.02	4.51	6.31	7.66	2.71	2.25	5.41	2.25
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.16	11.90	3.57	9.92	4.76	0.40	1.98	3.17	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	29.72	19.50	1.86	3.71	6.50	2.79	11.14	3.71	5.57
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	12.49	14.76	4.16	14.76	7.19	0.38	3.78	7.19	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	29.98	13.36	3.91	7.82	5.21	2.93	4.24	2.28	1.96
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	4.36	9.59	3.49	2.61	3.05	0.44	2.18	5.23	3.05
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	52.92	9.95	5.88	15.83	4.98	3.17	0.90	9.05	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	11.46	11.46	0.88	10.58	5.29	0.00	2.65	1.76	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	20.61	35.24	3.99	4.65	9.31	2.66	13.30	6.65	5.32
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.90	19.35	3.47	7.94	6.45	0.50	4.96	8.43	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	40.58	9.57	4.59	7.66	3.45	1.91	4.98	7.66	1.53
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	8.47	18.75	6.96	13.01	6.65	0.30	10.28	11.49	9.07
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	39.12	8.84	5.97	6.85	2.87	5.08	3.76	5.08	1.55
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.78	7.45	2.03	9.49	2.03	0.00	2.71	6.10	4.07
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	5.11	5.11	5.11	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.93	10.97	6.10	8.54	2.44	1.22	8.54	6.71	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	42.80	11.02	2.52	7.55	5.67	3.46	4.41	8.18	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	3.63	14.53	0.91	2.72	1.82	0.30	5.75	5.45	4.54
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	30.85	3.16	4.75	11.87	9.49	1.58	3.16	2.37	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	4.53	6.80	3.40	3.40	2.27	0.00	2.27	2.27	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	5.06	5.06	0.00	5.06	5.06	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	49.44	22.24	9.07	5.22	6.21	4.97	9.07	3.60	1.12
Myoblast, donor2	11322-117D8	78.63	28.77	14.58	7.48	10.16	7.48	9.59	6.52	3.07
Myoblast, donor3	11398-118D3	52.97	25.22	8.24	4.37	3.36	3.87	7.23	4.88	1.51
NK T cell leukemia cell line:KHYG-1	10777-110G3	11.97	0.00	1.02	0.00	0.29	1.75	0.00	1.02	0.00
Natural Killer Cells, donor1	11230-116C6	58.43	1.23	36.29	1.85	12.61	8.00	0.00	8.61	0.31
Natural Killer Cells, donor2	11311-117C6	79.31	1.51	31.66	8.14	11.76	5.13	0.30	10.55	0.00
Natural Killer Cells, donor3	11387-118C1	45.83	1.84	27.79	6.99	7.91	3.87	0.37	7.55	0.00
Neural stem cells, donor1	11275-116H6	0.73	14.88	9.44	6.17	1.45	0.36	0.73	1.09	11.61
Neural stem cells, donor2	11352-117H2	3.85	7.70	1.93	9.63	0.00	0.00	1.93	0.00	3.85
Neurons, donor1	11494-119E9	1.14	2.28	2.28	3.41	2.28	0.00	1.14	1.14	2.28
Neurons, donor2	11574-120E8	1.76	2.20	3.74	2.20	0.66	0.00	0.44	0.44	1.98
Neurons, donor3	11655-122E8	2.47	4.11	3.29	1.64	0.82	0.00	0.82	0.00	4.11
Neutrophils, donor1	11233-116C9	25.98	0.93	12.99	0.93	0.93	1.86	0.00	0.00	2.78
Neutrophils, donor2	11314-117C9	2.90	0.00	11.60	0.00	5.80	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	83.69	0.61	29.93	0.00	7.94	19.55	0.61	0.61	7.33
Nucleus Pulposus Cell, donor1	11252-116F1	142.96	19.12	16.39	8.07	15.55	12.35	3.09	12.35	11.16
Nucleus Pulposus Cell, donor2	11409-118E5	115.59	17.26	5.54	3.91	12.37	11.40	2.93	11.72	6.19
Nucleus Pulposus Cell, donor3	11462-119B4	101.48	28.48	6.42	3.01	9.23	10.03	5.21	7.22	4.41
Olfactory epithelial cells, donor1	11933-125I7	39.78	11.01	8.53	23.54	10.87	4.54	6.06	7.02	2.75
Olfactory epithelial cells, donor2	11934-125I8	37.20	16.94	6.95	22.15	9.41	2.89	8.25	5.50	2.03
Olfactory epithelial cells, donor3	11935-125I9	69.24	10.90	8.85	34.51	7.49	4.77	5.90	3.86	1.93
Olfactory epithelial cells, donor4	11936-126A1	40.42	28.73	15.29	25.32	11.69	2.43	10.62	6.43	5.45
Oligodendrocyte - precursors, donor1	11496-119F2	89.67	9.03	10.83	6.62	2.41	7.22	3.01	2.41	3.01
Osteoblast - differentiated, donor1	11276-116H7	89.12	34.46	10.63	6.17	14.46	5.10	10.85	14.46	8.93
Osteoblast - differentiated, donor2	11353-117H3	59.44	9.14	9.14	2.29	11.43	2.29	4.57	10.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	26.07	21.10	3.10	3.72	8.07	3.10	2.48	3.72	3.72
Osteoblast, donor1	11277-116H8	42.80	23.06	6.25	9.19	8.40	3.91	6.25	6.25	4.10
Osteoblast, donor2	11354-117H4	49.86	40.73	5.62	7.02	4.92	7.02	8.43	2.11	3.51
Osteoblast, donor3	11426-118G4	68.60	27.37	11.73	8.89	8.18	5.69	9.42	9.60	6.58
Pancreatic stromal cells, donor1	11249-116E7	55.43	38.16	16.51	16.51	11.79	4.89	14.57	5.14	5.98
Pericytes, donor1	11491-119E6	35.61	17.91	17.14	14.58	7.34	2.78	1.89	12.46	9.12
Pericytes, donor2	11571-120E5	28.52	27.62	12.45	13.58	7.47	4.30	4.30	6.56	4.75
Pericytes, donor3	11652-122E5	123.49	25.84	18.72	20.14	6.10	11.60	7.93	8.14	5.29
Perineurial Cells, donor1	11499-119F5	21.36	20.00	11.87	13.79	7.80	1.58	3.16	6.67	8.14
Perineurial Cells, donor2	11579-120F4	5.61	2.67	4.51	1.47	3.86	1.29	1.38	1.38	2.58
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	65.98	8.61	35.38	3.82	12.11	5.10	1.91	8.61	1.91
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	48.24	8.08	24.73	4.90	10.28	5.39	1.96	6.61	2.94
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	61.34	6.34	26.14	6.21	8.93	6.34	1.68	7.76	1.81
Placental Epithelial Cells, donor1	11278-116H9	186.55	16.98	12.44	78.45	3.59	4.07	2.63	0.96	1.91
Placental Epithelial Cells, donor2	11355-117H5	154.14	9.98	13.31	44.36	5.54	8.87	1.11	2.22	9.98
Placental Epithelial Cells, donor3	11427-118G5	135.47	15.71	10.41	46.92	1.18	7.07	3.93	1.77	7.26
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.03	7.91	0.95	0.00	4.43	0.32	2.85	1.27	0.32
Preadipocyte - breast, donor1	11467-119B9	57.03	39.21	10.13	2.44	17.07	1.31	8.82	6.75	1.31
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	267.06	92.67	40.59	6.66	36.81	25.71	31.59	25.71	3.39
Preadipocyte - breast, donor2	11328-117E5	66.64	31.75	10.36	3.60	15.31	5.63	13.28	8.11	1.13
Preadipocyte - omental, donor1	11468-119C1	51.79	36.87	8.84	2.77	20.03	2.56	10.55	6.29	2.02
Preadipocyte - omental, donor2	11329-117E6	91.22	27.06	11.78	2.62	14.84	2.62	6.55	8.73	3.06
Preadipocyte - omental, donor3	11403-118D8	43.12	42.69	8.59	6.45	17.91	3.01	13.47	5.59	1.58
Preadipocyte - perirenal, donor1	11469-119C2	62.99	32.48	8.86	0.00	12.80	1.97	10.83	5.91	3.94
Preadipocyte - subcutaneous, donor1	11279-116I1	66.64	36.55	11.06	7.06	8.60	4.61	8.29	4.61	1.54
Preadipocyte - subcutaneous, donor2	11356-117H6	29.93	41.26	9.56	8.32	4.43	5.14	11.51	1.42	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	26.39	47.17	10.73	3.07	5.79	4.60	13.79	5.11	1.70
Preadipocyte - visceral, donor1	11280-116I2	36.05	60.64	10.90	6.24	8.20	3.26	16.67	3.35	3.26
Preadipocyte - visceral, donor2	11357-117H7	28.99	41.88	7.36	2.76	7.82	5.06	13.81	5.06	1.84
Preadipocyte - visceral, donor3	11429-118G7	38.77	42.84	7.94	3.97	5.02	6.37	12.02	2.82	1.78
Prostate Epithelial Cells (polarized), donor1	11253-116F2	27.46	0.00	4.22	4.07	2.41	3.77	0.00	0.75	0.75
Prostate Epithelial Cells, donor2	11331-117E8	156.00	4.20	16.39	8.67	6.50	11.24	0.81	0.41	1.49
Prostate Epithelial Cells, donor3	11404-118D9	124.86	1.41	6.61	4.59	3.43	4.65	0.49	0.06	0.98
Prostate Stromal Cells, donor1	11254-116F3	32.12	19.70	9.91	15.83	5.70	3.53	4.78	4.90	1.59
Prostate Stromal Cells, donor2	11332-117E9	39.98	24.74	5.74	16.85	4.66	3.05	10.58	3.94	1.79
Prostate Stromal Cells, donor3	11405-118E1	18.87	10.84	10.64	14.08	5.01	2.09	3.75	3.02	3.55
Renal Cortical Epithelial Cells, donor1	11516-119H4	65.33	6.57	11.31	10.95	5.47	5.84	1.09	2.19	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	22.46	3.47	6.03	4.85	3.67	2.77	0.76	1.04	1.66
Renal Epithelial Cells, donor1	11517-119H5	145.07	25.87	16.23	17.75	6.59	19.27	5.58	2.54	1.01
Renal Epithelial Cells, donor2	11597-120H4	101.01	10.67	7.11	13.52	7.82	11.38	4.98	3.56	5.69
Renal Epithelial Cells, donor3	11678-122H4	46.58	3.07	11.43	7.83	4.34	4.55	0.95	2.33	2.65
Renal Glomerular Endothelial Cells, donor1	11514-119H2	25.87	9.53	8.17	0.00	2.72	8.17	0.68	3.40	6.13
Renal Glomerular Endothelial Cells, donor2	11594-120H1	32.07	14.69	4.72	0.54	1.21	6.06	4.31	1.62	2.16
Renal Glomerular Endothelial Cells, donor3	11675-122H1	67.94	13.10	5.99	8.44	3.11	9.99	4.00	2.22	1.78
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.29	2.66	2.66	7.32	5.32	5.32	1.33	4.66	4.66
Renal Mesangial Cells, donor1	11518-119H6	111.58	15.63	19.59	18.49	9.90	15.19	4.84	4.40	6.16
Renal Mesangial Cells, donor2	11598-120H5	99.69	21.94	16.93	8.78	10.03	15.67	3.76	5.64	8.78
Renal Mesangial Cells, donor3	11679-122H5	93.49	9.15	14.98	17.48	4.99	9.71	3.05	6.38	6.94
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	150.05	15.84	11.81	11.27	4.56	19.59	2.15	0.81	2.68
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	101.21	3.37	8.86	4.22	5.90	10.54	1.69	0.42	3.37
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	108.96	17.55	10.99	12.54	5.01	14.66	4.63	2.12	2.12
Retinal Pigment Epithelial Cells, donor0	11215-116A9	20.74	5.19	3.89	5.44	2.59	2.07	1.56	0.52	3.37
Retinal Pigment Epithelial Cells, donor1	11528-119I7	61.11	6.54	4.83	4.55	6.25	4.55	1.99	2.27	3.41
Retinal Pigment Epithelial Cells, donor2	11608-120I6	31.90	11.32	4.12	5.15	3.09	2.06	3.09	3.09	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	29.61	7.53	2.76	8.78	4.27	1.00	3.26	3.01	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	12.03	0.94	7.35	34.34	9.35	2.00	0.40	4.54	2.14
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	15.19	25.02	11.61	10.72	5.36	0.00	7.15	8.93	5.36
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	8.26	13.76	3.85	7.15	3.30	0.55	3.85	6.05	6.60
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.02	9.86	8.12	9.86	2.32	1.16	1.16	4.06	8.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	33.55	34.07	9.49	9.10	3.25	3.90	2.99	4.81	5.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	30.39	29.99	11.22	14.10	2.58	3.48	7.25	8.44	13.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	39.37	37.25	15.50	17.62	5.80	4.35	7.36	9.03	15.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	32.62	34.36	9.30	14.76	5.21	5.83	6.70	7.44	8.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	31.70	32.05	12.59	14.34	3.15	3.85	7.23	7.69	8.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	27.27	38.60	12.48	18.26	3.00	5.78	9.94	6.93	16.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	29.02	28.34	6.85	9.31	2.33	3.29	7.94	5.48	5.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	31.46	38.57	14.37	17.09	4.84	3.63	7.87	6.50	10.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	46.95	48.02	18.64	15.41	5.02	6.27	6.63	8.24	13.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	31.70	30.70	8.18	10.19	2.58	7.03	5.88	9.18	5.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	30.58	33.70	11.91	14.17	3.43	4.40	6.44	8.05	10.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	31.20	32.31	8.41	14.38	4.43	5.09	5.31	9.96	11.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	29.06	30.21	8.41	8.79	3.44	4.59	9.56	6.12	6.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	31.86	33.63	12.48	14.91	3.63	3.35	8.20	7.27	13.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	42.84	36.64	17.48	15.78	4.51	3.76	7.14	9.96	12.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	32.91	32.38	6.37	9.82	3.98	4.25	5.71	9.55	5.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	32.22	31.34	11.10	15.09	3.70	4.87	7.98	7.88	12.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	40.48	32.08	11.84	17.76	4.20	5.92	5.54	9.55	15.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	33.96	32.04	7.05	9.82	3.74	5.45	7.05	8.76	7.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	35.32	41.77	13.45	11.49	3.92	3.08	7.01	10.37	12.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	44.60	33.84	14.36	9.40	4.44	8.03	7.86	10.25	12.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	39.75	35.19	4.92	8.39	4.01	5.83	8.57	8.93	7.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	37.16	38.38	9.81	15.21	3.56	5.52	8.09	9.07	11.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	40.30	42.98	15.04	20.15	6.58	6.72	6.45	11.69	19.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	33.73	29.25	8.96	8.26	2.83	4.48	9.43	4.72	4.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	38.69	39.09	9.13	12.70	4.37	4.96	5.95	6.75	10.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	53.32	46.07	12.86	17.07	7.02	5.85	10.99	10.06	16.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	34.42	32.14	6.64	9.33	2.90	4.56	7.05	8.50	6.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	42.25	43.36	11.95	8.63	5.53	5.97	6.19	9.73	15.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	43.45	40.11	14.62	18.80	5.43	4.60	9.19	11.70	13.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	43.20	34.99	7.27	11.04	5.65	6.33	9.96	8.88	5.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	49.22	33.55	10.05	18.05	5.96	5.79	8.86	9.20	12.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	53.79	37.21	14.46	16.77	7.13	5.98	8.68	12.15	12.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	39.37	31.29	7.05	11.18	5.50	7.22	9.97	10.14	5.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	43.07	36.21	10.29	16.05	5.76	4.94	9.88	13.44	12.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	49.74	42.36	11.33	16.75	6.24	5.75	8.04	14.94	11.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	23.52	28.80	8.01	8.35	2.90	4.94	7.67	5.97	6.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	27.52	24.86	8.43	14.50	3.99	4.44	5.77	8.29	12.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	33.32	26.12	13.06	13.86	4.26	3.20	8.26	9.86	9.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	9.96	23.78	7.88	12.31	3.18	2.35	5.53	6.78	10.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	11.91	18.33	13.57	14.52	2.86	1.90	5.24	6.19	16.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	22.37	28.62	15.92	17.13	4.03	2.82	7.05	8.26	14.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	15.54	28.16	9.23	8.29	4.52	3.01	6.87	8.29	8.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	25.50	34.24	10.13	13.63	3.49	3.49	5.24	13.63	19.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	37.47	27.50	12.69	10.28	7.56	1.21	8.46	12.09	13.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	17.13	41.86	7.96	10.28	3.55	4.04	10.40	9.42	7.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	104.94	121.68	41.19	49.63	15.72	5.53	20.52	36.24	47.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	46.24	41.98	12.78	26.77	6.08	4.26	9.13	19.47	29.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	24.41	26.82	6.33	11.15	3.01	4.52	8.44	7.23	7.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	34.61	43.88	15.38	27.37	7.46	2.26	8.82	13.35	24.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	33.25	49.42	20.97	29.35	4.79	3.59	12.28	16.47	32.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	29.52	37.78	8.38	15.59	6.49	1.89	5.79	9.92	11.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	29.24	42.48	14.73	26.25	4.70	3.63	10.67	14.09	26.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	43.27	33.05	18.03	30.65	3.00	3.00	10.82	27.04	32.45
Schwann Cells, donor1	11498-119F4	52.47	30.47	15.61	6.77	9.03	7.52	7.33	5.08	4.14
Schwann Cells, donor2	11578-120F3	27.22	23.82	6.80	10.21	0.00	6.80	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	37.68	21.25	9.86	8.54	5.48	5.48	6.13	5.70	3.29
Sebocyte, donor1	11220-116B5	196.10	7.67	21.91	24.10	3.29	17.53	1.64	0.55	0.00
Sebocyte, donor2	11301-117B5	180.60	10.11	16.54	7.35	7.35	15.62	0.92	0.92	0.00
Sebocyte, donor3	11378-118B1	50.70	19.17	11.34	6.18	3.30	4.33	2.89	2.06	0.62
Sertoli Cells, donor1	11255-116F4	43.07	29.82	8.28	4.97	19.88	1.66	18.22	3.31	1.66
Sertoli Cells, donor2	11333-117F1	62.14	48.01	5.65	8.47	22.59	5.65	2.82	11.30	8.47
Skeletal Muscle Cells, donor1	11281-116I3	8.62	44.43	3.61	4.40	3.43	0.97	7.13	4.05	2.90
Skeletal Muscle Cells, donor2	11358-117H8	12.29	18.79	1.45	13.01	5.78	2.17	4.34	5.06	1.45
Skeletal Muscle Cells, donor3	11430-118G8	42.64	81.93	10.87	11.70	4.18	8.36	20.90	6.69	11.70
Skeletal Muscle Cells, donor4	11451-119A2	10.84	17.12	3.46	3.46	3.30	0.94	4.87	1.57	2.98
Skeletal Muscle Cells, donor5	11455-119A6	9.66	14.42	2.68	5.80	3.12	2.23	3.72	2.82	2.97
Skeletal Muscle Cells, donor6	11459-119B1	24.47	30.47	3.39	12.77	2.31	2.62	7.85	4.16	1.69
Skeletal Muscle Satellite Cells, donor1	11240-116D7	37.80	17.01	17.01	6.17	9.45	5.42	4.54	6.55	7.94
Skeletal Muscle Satellite Cells, donor2	11321-117D7	64.78	17.41	11.13	5.42	8.56	10.70	4.42	7.99	7.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	26.89	30.46	6.35	12.90	4.17	3.47	7.34	2.88	5.26
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	13.65	26.88	6.07	14.58	4.72	0.59	3.88	6.23	1.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	90.47	47.04	5.79	12.30	3.62	15.92	13.03	2.90	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	21.05	26.83	5.64	2.89	6.33	2.75	6.74	5.92	4.40
Skin - palm, donor1	10286-104F7	271.30	8.06	10.74	5.37	16.12	2.69	0.00	29.55	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	98.75	8.51	8.51	5.19	3.03	7.93	3.89	0.72	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	657.58	31.08	83.42	38.44	14.72	47.44	5.73	1.64	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	93.48	10.13	7.53	5.71	3.12	6.10	3.38	0.26	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	205.18	5.98	15.01	15.43	6.39	10.01	1.25	0.70	2.09
Small Airway Epithelial Cells, donor2	11334-117F2	262.47	6.47	17.72	18.14	5.49	12.80	2.81	0.56	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	1008.60	42.08	85.64	60.47	18.18	78.02	10.36	2.11	2.75
Small Airway Epithelial Cells, donor3	11406-118E2	155.75	3.75	11.24	8.47	5.10	5.40	1.65	0.22	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	17.28	6.79	3.39	0.93	1.54	1.23	3.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	147.18	142.74	19.12	4.45	17.12	17.34	51.36	21.34	3.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	59.37	37.62	14.11	4.11	12.34	6.47	7.64	4.11	6.47
Smooth Muscle Cells - Aortic, donor1	11283-116I5	19.89	36.68	9.94	6.41	3.31	1.77	5.30	1.33	1.55
Smooth Muscle Cells - Aortic, donor2	11360-117I1	25.99	20.48	9.06	2.76	4.73	1.97	4.73	4.33	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	64.12	35.54	15.45	3.86	17.77	2.32	10.82	5.41	3.09
Smooth Muscle Cells - Bladder, donor1	11519-119H7	3.00	12.01	4.00	6.00	1.00	1.00	0.00	2.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	27.95	29.41	11.84	3.73	5.19	2.40	8.65	4.26	2.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	17.07	34.13	6.87	7.09	8.87	1.77	13.30	5.32	3.99
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	7.43	3.58	1.41	1.92	0.64	1.15	1.15	1.15	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	29.30	3.58	11.07	6.19	6.84	1.95	0.65	7.16	7.16
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	59.36	15.36	12.70	13.58	10.34	3.25	5.91	7.68	4.13
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	72.32	7.12	8.40	8.26	3.56	8.54	2.28	2.85	3.99
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	176.50	56.94	21.80	17.57	16.43	14.97	14.32	8.62	6.02
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	95.90	41.10	10.96	9.13	13.40	5.78	11.57	11.26	7.92
Smooth Muscle Cells - Carotid, donor1	11285-116I7	44.70	70.47	15.66	2.78	17.43	4.80	17.43	13.13	5.81
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	6.12	6.12	0.00	6.12	0.00	6.12	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	18.60	20.98	2.86	3.34	1.91	4.77	4.77	0.95	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	32.59	16.07	7.08	7.37	9.29	2.95	4.72	3.10	2.36
Smooth Muscle Cells - Colonic, donor2	11320-117D6	20.66	9.90	6.46	4.09	5.38	3.01	4.74	3.23	3.44
Smooth Muscle Cells - Colonic, donor3	11396-118D1	25.08	14.38	7.35	8.50	6.09	2.94	6.93	4.20	6.09
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	27.69	14.69	8.04	2.32	5.88	2.17	4.95	1.86	2.78
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	20.48	15.09	12.93	4.31	9.70	2.16	5.39	7.55	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	20.02	15.54	5.08	4.18	4.78	1.49	4.18	2.09	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	99.01	22.19	14.00	23.56	5.80	10.92	4.44	3.76	6.83
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	35.81	8.48	14.45	7.38	6.91	2.12	1.96	6.36	7.93
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	57.87	64.41	19.63	12.68	13.08	3.02	13.59	4.13	3.12
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	11.61	15.93	4.78	6.37	2.05	0.68	5.92	1.82	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	22.34	19.93	10.26	1.21	4.23	1.21	4.23	2.42	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	35.50	11.66	3.18	5.56	2.12	5.56	2.38	1.06	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	23.04	21.70	7.06	10.39	4.39	2.13	4.53	3.20	1.86
Smooth Muscle Cells - Prostate, donor2	11335-117F3	22.29	17.03	8.51	6.01	6.76	2.13	5.89	2.00	2.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	4.06	11.16	11.92	7.10	8.62	0.00	5.33	5.33	3.30
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	59.10	64.23	16.74	1.51	14.93	4.22	18.39	7.54	4.37
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	26.26	45.76	17.25	1.50	14.25	2.25	13.50	10.50	4.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	31.01	345.02	2.58	0.00	2.58	2.58	6.46	1.29	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	55.34	74.88	17.67	0.47	19.53	5.58	21.39	6.98	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.57	26.76	5.05	3.03	4.54	1.51	10.60	3.03	2.52
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	7.83	13.16	4.70	5.33	3.76	0.63	6.89	2.51	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	129.21	27.43	15.34	6.49	11.80	5.60	7.67	7.37	6.49
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	64.90	12.00	3.58	8.00	2.00	7.58	2.67	3.17	1.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	72.41	20.56	8.88	3.27	7.94	8.88	5.14	6.07	8.88
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	30.22	10.07	12.66	14.82	5.47	2.88	2.73	3.17	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	32.38	14.28	8.92	20.91	5.61	3.82	4.59	3.31	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	7.52	16.36	3.57	5.64	2.44	0.75	6.96	2.82	1.50
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	68.47	17.19	7.13	17.05	4.33	9.22	4.47	3.91	2.10
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	94.09	17.18	10.47	20.86	8.04	10.14	6.37	5.87	2.09
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	55.71	14.29	6.19	11.90	5.71	8.10	3.33	2.38	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	23.73	9.54	10.77	21.29	5.14	2.20	2.20	2.20	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	43.75	18.12	6.85	13.48	5.30	3.31	3.76	2.87	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	21.07	39.79	11.12	8.48	2.34	2.05	9.07	4.10	3.80
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	15.55	24.68	10.30	1.17	5.83	0.97	5.83	3.30	2.53
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	56.59	25.39	10.58	0.79	9.78	2.12	4.50	5.29	2.64
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.58	9.67	5.58	1.12	3.35	1.12	1.86	1.49	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	31.98	16.17	14.01	7.91	7.19	1.80	3.95	2.52	3.23
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	32.08	15.05	13.06	9.08	4.83	1.70	3.69	3.69	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	18.12	20.48	5.51	5.12	3.94	0.39	5.12	2.76	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	9.14	13.97	6.86	1.27	2.03	0.76	4.57	1.78	3.30
Smooth muscle cells - airway, control, donor2	11967-126D5	6.39	14.38	7.19	1.60	3.99	1.20	4.79	2.80	2.80
Smooth muscle cells - airway, control, donor3	11968-126D6	10.03	17.56	11.70	2.09	5.43	1.67	4.60	2.51	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	16.50	11.92	12.83	0.92	7.79	0.92	1.83	3.21	2.29
Synoviocyte, donor1	11291-117A4	70.19	42.75	13.47	28.28	13.97	3.03	12.12	7.74	1.51
Synoviocyte, donor2	11368-117I9	18.94	43.75	7.21	2.18	17.10	1.34	15.09	8.72	5.70
Synoviocyte, donor3	11440-118H9	14.07	29.27	4.69	3.80	11.17	2.23	13.85	5.14	3.13
Trabecular Meshwork Cells, donor1	11532-120A2	185.10	58.96	18.22	12.15	10.01	21.08	15.72	5.36	4.65
Trabecular Meshwork Cells, donor2	11612-122A1	73.34	17.84	1.98	5.95	5.95	5.95	7.93	0.00	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	84.98	25.93	10.19	4.86	6.02	8.34	5.33	5.79	3.94
Tracheal Epithelial Cells, donor1	11292-117A5	130.18	3.66	13.05	7.89	2.44	9.32	1.15	0.36	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	224.59	10.05	18.94	10.44	5.41	11.98	3.48	1.55	3.48
Tracheal Epithelial Cells, donor3	11441-118I1	233.65	6.30	8.02	13.74	4.01	18.90	2.86	0.00	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	10.95	1.48	8.12	33.95	7.63	1.48	0.37	4.92	2.58
Urethra, donor2	10319-105A4	53.95	1.80	14.39	28.77	5.40	3.60	3.60	16.19	5.40
Urothelial Cells, donor1	11520-119H8	265.93	9.30	30.29	16.47	7.97	23.64	1.06	0.53	2.92
Urothelial Cells, donor2	11600-120H7	217.51	6.01	24.84	15.62	7.21	17.22	0.80	0.80	3.61
Urothelial Cells, donor3	11681-122H7	233.33	5.04	24.07	19.02	6.65	17.65	2.06	0.46	1.15
Urothelial cells, donor0	11216-116B1	172.08	3.34	20.28	14.27	4.24	10.92	0.45	0.45	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	40.04	1.78	24.02	0.89	8.90	7.12	0.00	4.45	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	30.02	7.15	28.59	0.00	5.72	12.87	0.00	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	36.96	0.68	18.48	3.42	10.27	4.79	2.05	7.53	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	44.08	3.79	23.41	3.44	15.15	3.79	0.34	6.20	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	44.74	2.91	25.57	2.91	13.36	1.16	0.00	6.97	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	35.40	6.25	21.87	5.21	9.37	9.37	0.00	6.25	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	34.88	1.84	23.86	3.67	7.34	3.67	0.92	6.42	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	30.13	1.83	21.91	1.83	10.04	5.48	0.00	5.48	0.00
Wilms' tumor cell line:G-401	10809-111A8	0.25	11.72	4.93	0.00	0.00	0.00	1.73	0.37	6.29
Wilms' tumor cell line:HFWT	10597-108E3	0.00	0.00	3.52	0.88	0.00	0.00	0.00	0.00	3.52
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	234.63	4.75	28.21	0.00	7.26	18.16	0.28	2.51	0.00
achilles tendon, donor2	10292-104G4	62.00	22.73	8.27	2.07	10.33	0.00	6.20	33.06	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	10.71	0.00	7.65	0.76	0.76	4.08	0.00	0.76	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1.39	0.00	0.70	0.00	0.46	0.46	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	4.51	0.00	0.12	0.24	0.36	1.42	0.00	0.71	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	5.99	0.00	8.44	1.90	0.54	2.18	0.00	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	9.56	0.00	14.34	0.00	1.12	1.69	0.00	5.06	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	17.34	0.00	12.27	0.63	2.11	4.44	0.00	6.34	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	8.44	0.27	6.53	0.00	2.18	2.45	0.00	6.26	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.00	0.00	18.51	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	4.90	0.00	8.17	0.00	2.45	2.86	0.00	11.03	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	4.27	0.00	25.63	0.00	5.05	1.94	0.00	6.21	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	1.47	0.00	5.70	0.00	0.18	0.55	0.00	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	7.80	0.00	3.90	0.00	0.00	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	21.61	0.00	16.96	0.00	6.04	8.83	0.00	6.51	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	19.68	0.78	16.57	0.00	0.52	5.95	0.26	2.59	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	5.55	0.29	14.03	0.58	0.29	2.34	0.00	0.29	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	7.90	1.86	19.52	1.39	0.93	5.11	1.39	3.25	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	4.94	0.00	12.34	0.00	0.82	0.00	0.00	4.52	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.61	5.83	11.36	0.00	0.00	1.23	2.46	2.15	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	2.56	8.11	23.04	0.00	0.85	0.43	0.85	0.85	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	2.12	6.98	13.04	0.00	0.61	0.30	0.91	0.30	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	3.37	10.59	18.29	0.00	0.96	0.48	0.96	1.20	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	15.59	0.00	20.94	0.22	0.00	4.45	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	1.33	19.01	9.01	0.00	2.00	0.00	3.67	1.67	3.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	16.72	0.00	11.15	0.00	1.86	1.86	0.00	3.72	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	51.98	0.00	18.83	0.00	4.14	10.55	0.00	6.03	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	1.74	0.00	0.44	0.00	0.44	0.44	0.00	1.31	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	15.00	0.00	3.75	0.00	7.50	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	69.71	3.06	12.72	4.71	1.41	2.35	0.94	1.65	0.24
adipose tissue, adult, pool1	10010-101C1	29.94	12.72	15.51	3.72	8.69	3.88	2.17	11.17	2.33
adipose, donor1	10184-103D4	1.17	0.00	0.59	1.76	0.00	0.00	0.00	0.00	3.52
adipose, donor2	10185-103D5	0.00	0.41	1.62	2.84	0.41	0.00	0.41	0.41	6.08
adipose, donor3	10186-103D6	0.27	0.82	1.36	2.45	0.00	0.00	0.00	0.27	6.26
adipose, donor4	10187-103D7	0.00	1.73	0.87	4.33	0.87	0.00	0.00	0.00	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	0.00	0.00	5.05	0.00	0.00	0.00	0.00	0.16	1.26
adrenal gland, adult, pool1	10081-102A9	10.91	0.00	14.55	7.28	0.00	0.00	0.00	10.91	7.28
adult T-cell leukemia cell line:ATN-1	10421-106C7	54.16	18.68	10.01	0.27	2.93	4.54	2.53	3.07	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	42.52	24.30	8.22	5.36	5.72	7.15	8.22	2.14	1.07
amniotic membrane cells, donor1	12235-129G3	374.90	15.53	35.24	59.35	14.84	13.22	5.33	8.11	11.59
amniotic membrane cells, donor2	12236-129G4	89.60	5.07	15.55	30.43	9.80	4.40	0.00	1.35	1.35
amniotic membrane cells, donor3	12237-129G5	354.99	11.49	27.40	42.42	15.32	12.96	5.60	6.19	3.83
amygdala - adult, donor10196	10167-103B5	2.37	2.37	29.64	8.30	1.19	0.00	0.00	2.37	4.74
amygdala, adult, donor10252	10151-102I7	1.22	2.43	42.78	16.02	1.22	0.20	1.42	1.22	22.10
amygdala, newborn, donor10223	10360-105E9	2.90	5.49	25.82	8.39	1.29	0.00	0.00	1.29	2.90
anaplastic carcinoma cell line:8305C	10428-106D5	103.90	10.82	12.99	43.16	13.75	6.37	2.55	7.77	2.04
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	47.88	18.53	3.53	1.32	1.76	12.35	5.07	0.88	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	4.01	11.36	18.04	0.00	2.67	1.00	1.00	0.67	5.68
aorta, adult, pool1	10052-101G7	14.91	16.67	10.59	15.49	11.57	0.98	6.67	21.77	4.71
appendix, adult	10189-103D9	36.48	2.33	19.79	17.47	13.20	4.27	1.16	8.15	3.10
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	0.00	0.00	4.13	1.72	0.34	0.00	0.00	0.00	0.34
artery, adult	10190-103E1	13.59	10.87	2.72	50.27	6.79	2.72	1.36	10.87	2.72
astrocytoma cell line:TM-31	10425-106D2	63.74	11.88	9.13	0.72	4.78	12.60	1.74	3.62	2.32
b cell line:RPMI1788	10427-106D4	3.57	0.00	3.57	1.78	1.64	2.68	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	45.22	15.81	13.32	4.99	9.43	3.33	4.16	3.88	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	171.97	10.52	12.90	43.86	5.46	10.82	2.68	1.39	1.39
bile duct carcinoma cell line:TFK-1	10496-107C1	70.47	13.06	2.85	7.53	6.03	2.51	2.85	0.50	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	12.30	2.24	22.93	1.68	0.56	2.24	0.56	3.36	2.24
bladder, adult, pool1	10011-101C2	14.01	9.67	5.87	27.81	6.95	1.09	2.17	6.95	2.06
blood, adult, pool1	10053-101G8	11.07	0.00	15.50	4.43	0.00	2.21	0.00	6.64	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	226.08	20.55	14.56	5.99	16.27	11.99	8.56	10.28	2.57
bone marrow, adult	10192-103E3	15.52	10.12	9.45	9.45	6.07	1.35	3.37	6.07	11.47
brain, adult, donor1	10084-102B3	1.03	3.08	30.75	9.23	0.00	0.00	1.03	0.00	5.13
brain, adult, pool1	10012-101C3	4.23	2.00	26.17	8.91	0.78	0.33	0.67	1.11	6.57
brain, fetal, pool1	10085-102B4	8.01	2.67	13.36	8.01	0.00	0.00	0.00	2.67	5.34
breast carcinoma cell line:MCF7	10482-107A5	0.00	0.00	15.86	9.58	3.96	0.00	0.00	3.30	3.30
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.12	0.00	19.35	2.50	12.86	0.00	0.12	5.49	4.74
breast, adult, donor1	10080-102A8	12.63	3.16	6.31	1.89	5.05	1.89	0.00	2.53	3.16
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	111.67	11.31	6.22	16.64	4.32	8.13	1.40	2.03	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	235.63	10.82	15.77	17.63	6.49	25.05	2.47	4.95	7.73
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	30.39	14.27	4.37	0.23	2.99	10.82	2.99	1.15	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	90.06	6.29	12.10	31.71	7.75	5.57	2.42	3.39	3.15
carcinoid cell line:NCI-H1770	10703-109H1	0.00	0.00	3.29	4.23	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	3.17	3.83	2.95	1.42	0.98	0.22	1.20	0.66	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	0.32	0.95	2.85	3.17	0.63	0.32	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	0.00	1.86	5.32	7.19	0.53	0.00	0.00	0.27	1.06
caudate nucleus - adult, donor10196	10177-103C6	3.45	1.15	12.66	9.21	0.00	0.00	0.00	1.15	9.21
caudate nucleus, adult, donor10252	10164-103B2	1.17	1.34	37.98	3.51	2.18	0.33	0.50	2.84	8.20
caudate nucleus, adult, donor10258	10379-105H1	2.29	2.29	46.61	8.41	0.00	0.76	2.29	2.29	1.53
caudate nucleus, newborn, donor10223	10354-105E3	0.37	0.73	28.57	4.03	0.73	0.37	0.00	0.73	1.46
cerebellum - adult, donor10196	10173-103C2	5.83	0.00	23.31	8.74	0.00	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	1.92	1.92	52.74	11.96	1.92	0.21	0.21	2.56	11.74
cerebellum, adult, pool1	10083-102B2	0.69	0.00	17.59	5.17	0.00	0.00	0.00	1.03	4.48
cerebellum, newborn, donor10223	10357-105E6	0.00	1.66	33.21	5.81	0.00	0.00	0.00	0.00	4.98
cerebral meninges, adult	10188-103D8	2.27	0.00	26.98	4.79	1.76	0.00	0.00	3.28	3.28
cerebrospinal fluid, donor2	10294-104G6	23.39	3.65	11.69	14.62	1.46	3.65	0.73	4.39	0.73
cervical cancer cell line:D98-AH2	10552-107I3	15.67	7.91	4.46	8.63	1.73	0.72	0.58	0.29	1.15
cervical cancer cell line:ME-180	10553-107I4	134.56	18.23	13.92	0.00	6.30	3.31	5.30	0.99	0.00
cervix, adult, pool1	10013-101C4	25.20	12.49	13.86	23.10	12.70	2.31	2.10	7.35	10.71
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	86.67	4.88	19.79	0.00	6.27	7.80	3.34	4.32	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	169.81	16.98	13.06	1.31	9.14	14.37	0.00	13.06	2.61
choriocarcinoma cell line:BeWo	10423-106C9	1.74	0.00	8.20	19.39	1.24	0.50	0.00	0.00	3.23
choriocarcinoma cell line:SCH	10785-110H2	12.81	0.00	5.17	46.82	0.99	2.59	0.00	0.12	2.71
choriocarcinoma cell line:T3M-3	10618-108G6	15.65	0.00	4.03	2.85	0.24	9.72	0.00	0.00	0.47
chorionic membrane cells, donor1	12238-129G6	119.95	4.56	17.95	54.42	8.26	7.98	1.42	3.99	9.40
chorionic membrane cells, donor2	12239-129G7	38.98	8.25	11.24	16.80	4.87	4.08	2.59	2.09	1.89
chorionic membrane cells, donor3	12240-129G8	115.39	1.10	12.09	52.20	9.34	10.99	0.55	2.75	5.49
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	1.01	0.00	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	9.99	23.63	14.22	0.00	5.19	1.73	4.61	9.22	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	1.06	0.63	4.01	0.00	0.63	0.00	0.21	2.32	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	5.39	4.88	3.85	5.14	1.28	1.54	1.03	1.03	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	8.47	4.84	3.63	3.14	1.21	2.66	0.48	0.73	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	6.31	5.09	4.07	4.68	0.61	1.63	0.61	0.41	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	8.24	12.66	2.06	6.18	0.59	2.06	1.77	0.00	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	1.56	1.04	6.26	0.26	0.52	0.00	0.00	0.78	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	19.43	10.29	14.17	5.26	1.60	8.46	1.83	0.69	2.51
clear cell carcinoma cell line:TEN	10636-108I6	80.51	0.17	6.07	1.91	3.64	7.46	0.00	0.52	1.21
colon carcinoma cell line:CACO-2	10513-107D9	15.92	0.00	3.11	2.93	2.01	3.29	0.00	0.37	0.55
colon carcinoma cell line:COLO-320	10420-106C6	0.00	0.00	4.56	3.80	0.00	0.00	0.00	0.00	0.76
colon, adult, donor1	10082-102B1	76.16	2.38	8.33	17.85	4.76	5.95	0.00	16.66	1.19
colon, adult, pool1	10014-101C5	37.25	3.64	9.87	16.45	9.28	1.29	0.71	5.52	3.06
colon, fetal, donor1	10070-101I7	22.87	0.00	1.24	11.12	6.80	0.00	0.62	11.12	0.62
common myeloid progenitor CMP, donor1	12130-128D6	4.58	0.00	13.75	0.00	4.58	0.00	0.00	18.33	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	4.25	7.65	1.27	0.00	0.42	0.00	1.27	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	1.36	8.75	2.87	0.00	0.91	0.00	0.75	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	0.71	7.47	3.10	0.00	0.56	0.42	0.71	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	5.42	3.21	22.00	24.43	3.32	1.44	1.11	3.98	16.14
cruciate ligament, donor2	10295-104G7	68.08	9.73	10.54	4.86	10.54	4.86	4.05	16.21	2.43
diaphragm, fetal, donor1	10069-101I6	18.46	2.41	2.41	41.73	4.82	3.21	2.41	15.25	3.21
diencephalon, adult	10193-103E4	1.68	0.72	14.16	8.40	0.48	0.96	0.00	1.20	6.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	4.36	0.00	6.43	0.92	0.46	1.61	0.00	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	120.01	6.15	15.13	2.05	10.00	8.46	0.77	1.03	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	0.00	23.11	5.78	0.00	0.72	0.00	4.09	1.69	4.09
ductus deferens, adult	10196-103E7	11.96	1.50	20.43	21.93	11.46	0.00	0.50	7.48	7.97
duodenum, fetal, donor1, tech_rep1	10071-101I8	23.04	2.88	7.20	11.52	5.76	0.00	1.44	8.64	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	24.28	0.74	8.09	11.77	8.83	2.21	0.00	2.94	3.68
dura mater, adult, donor1	10041-101F5	60.29	33.12	15.61	12.39	10.08	6.36	7.10	15.11	11.15
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	0.89	0.00	0.22	7.55	0.00	0.22	0.00	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	0.14	0.00	3.30	1.86	0.29	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	268.84	27.13	7.40	26.51	12.95	13.57	9.25	2.47	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	121.99	28.15	12.41	13.02	6.96	13.92	8.17	2.12	3.33
embryonic pancreas cell line:1C3IKEI	10606-108F3	264.91	39.52	6.79	38.90	11.11	16.98	8.34	6.17	1.54
embryonic pancreas cell line:2C6	10603-108E9	254.81	24.96	3.94	38.09	2.63	15.76	2.63	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	32.85	4.69	10.73	0.00	8.38	2.35	1.68	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	3.81	28.82	15.59	1.99	2.17	0.72	4.35	3.99	3.62
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	42.78	0.00	19.30	3.06	5.79	2.73	0.00	4.18	2.73
epidermoid carcinoma cell line:A431	10426-106D3	177.08	3.78	15.90	5.67	3.45	4.11	1.33	0.33	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	184.12	16.50	12.65	1.87	5.83	12.65	3.63	0.44	0.55
epididymis, adult	10197-103E8	11.09	7.12	11.09	15.70	10.26	0.63	0.84	5.86	5.44
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	40.09	34.06	10.47	0.00	3.55	5.85	5.32	3.02	6.92
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	30.28	11.01	4.33	2.36	0.79	3.93	1.57	1.18	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	64.35	20.71	4.19	5.77	1.97	3.93	6.03	1.31	2.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	41.73	17.42	4.92	4.53	1.38	3.64	4.53	1.08	3.44
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	54.56	17.48	6.50	4.26	1.57	4.71	5.15	0.90	3.81
esophagus, adult, pool1	10015-101C6	49.48	6.90	10.94	19.86	8.60	4.03	1.91	4.88	1.70
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	0.00	6.76	4.13	0.75	0.88	0.00	0.38	0.13	3.76
eye - muscle inferior rectus, donor1	10272-104E2	21.73	9.66	2.41	24.15	9.66	2.41	4.83	21.73	9.66
eye - muscle lateral, donor2	10298-104H1	29.46	10.52	4.21	46.29	10.52	0.00	0.00	31.56	0.00
eye - muscle medial, donor2	10299-104H2	14.88	4.46	7.44	28.28	7.44	1.49	2.98	29.76	5.95
eye - muscle superior, donor2	10297-104G9	32.10	3.44	10.32	21.78	5.73	0.00	0.00	32.10	4.59
eye - vitreous humor, donor1	10268-104D7	34.98	4.37	17.49	8.74	4.37	4.37	2.91	5.83	1.46
eye, fetal, donor1	10054-101G9	12.46	0.25	7.88	9.41	8.64	1.53	0.76	6.10	3.81
fibrosarcoma cell line:HT-1080	10758-110E2	72.45	22.44	4.62	2.82	6.15	12.95	3.08	5.64	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	40.60	0.47	10.45	5.22	6.17	9.97	0.00	4.51	2.61
frontal lobe, adult, pool1	10040-101F4	2.44	1.31	43.91	6.00	0.84	0.09	0.28	1.97	6.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	150.73	0.00	13.81	10.81	7.81	8.11	0.00	2.10	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	61.81	5.76	18.74	4.30	6.95	4.39	1.01	2.38	2.10
gall bladder, adult	10198-103E9	63.74	3.86	15.45	23.18	10.38	1.93	1.69	7.24	7.00
gamma delta positive T cells, donor1	11937-126A2	22.01	0.00	23.62	2.15	7.52	2.68	0.00	4.83	0.00
gamma delta positive T cells, donor2	11938-126A3	21.66	1.12	21.66	1.49	7.47	1.49	0.37	4.86	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	150.60	16.26	44.36	31.05	12.25	10.14	6.34	6.13	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	119.14	48.93	16.05	5.22	19.73	7.16	7.74	9.09	0.19
gastric cancer cell line:AZ521	10549-107H9	0.00	7.38	8.36	0.00	0.00	0.00	0.33	0.00	1.80
gastric cancer cell line:GSS	10560-108A2	13.73	0.00	10.07	0.00	0.00	10.07	0.92	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	0.00	0.00	5.94	6.63	0.00	0.00	0.00	0.00	0.23
giant cell carcinoma cell line:LU65	10487-107B1	109.69	10.67	1.26	9.18	4.82	4.02	2.07	1.26	1.26
giant cell carcinoma cell line:Lu99B	10433-106E1	181.95	46.05	20.15	41.71	17.63	28.41	8.12	6.72	7.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	91.29	4.74	11.22	9.48	4.99	7.73	2.74	0.25	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	73.89	12.14	9.61	6.54	6.54	4.75	3.06	2.32	1.48
glioblastoma cell line:A172, tech_rep2	10444-106F3	81.31	16.57	8.57	7.72	6.88	5.62	4.49	1.40	3.65
glioblastoma cell line:T98G	10485-107A8	92.05	11.70	14.90	25.17	3.64	7.73	3.53	2.10	4.53
glioma cell line:GI-1	10413-106B8	0.88	5.56	9.96	4.39	1.17	0.00	0.88	0.29	1.46
globus pallidus - adult, donor10196	10175-103C4	8.75	0.00	15.31	8.02	1.46	1.46	0.00	0.73	5.10
globus pallidus, adult, donor10252	10161-103A8	2.69	4.15	20.99	17.33	2.44	1.22	1.22	2.20	17.57
globus pallidus, adult, donor10258	10367-105F7	2.74	4.11	9.58	20.54	0.00	1.37	0.00	1.37	5.48
globus pallidus, newborn, donor10223	10364-105F4	4.80	1.60	15.99	7.46	1.07	0.53	0.53	0.00	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	2.45	17.13	2.45	12.24	0.00	0.00	7.34	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	96.32	28.80	13.44	2.88	9.92	10.88	8.00	8.00	4.16
hIPS +CCl2, biol_rep1	14383-156B9	0.00	0.46	3.67	1.38	0.46	0.00	0.00	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	0.46	0.46	6.40	1.83	0.00	0.00	0.00	0.46	2.74
hIPS +CCl2, biol_rep3	14385-156C2	0.00	0.64	1.29	1.29	0.00	0.00	0.00	0.00	1.29
hIPS, biol_rep1	14380-156B6	0.00	0.00	1.44	2.87	0.00	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	0.69	0.00	2.06	2.74	1.37	0.00	0.69	0.00	3.43
hIPS, biol_rep3	14382-156B8	2.21	1.10	15.45	3.31	0.00	0.00	1.10	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	14.65	14.37	6.90	0.00	0.57	4.02	0.29	0.00	0.57
heart - mitral valve, adult	10205-103F7	15.85	11.36	6.58	7.18	3.89	0.00	4.78	7.47	3.29
heart - pulmonic valve, adult	10206-103F8	16.73	4.71	7.58	27.45	6.80	0.00	0.26	10.46	2.09
heart - tricuspid valve, adult	10207-103F9	17.49	8.33	8.33	11.66	5.00	0.00	1.67	4.16	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	30.20	4.08	5.92	26.73	2.45	2.24	1.43	8.77	3.47
heart, adult, diseased, donor1	10051-101G6	13.63	5.54	3.41	46.42	6.39	0.85	2.98	16.61	1.70
heart, adult, pool1	10016-101C7	11.96	2.99	3.91	27.14	6.21	1.38	0.92	8.28	2.76
heart, fetal, pool1	10046-101G1	12.63	4.31	4.93	43.23	3.08	0.92	0.51	5.85	2.77
hepatic mesenchymal tumor cell line:LI90	10778-110G4	76.82	12.03	11.72	11.42	14.19	6.48	6.48	9.56	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	9.51	0.00	2.38	10.70	1.19	0.00	0.00	0.00	4.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	0.00	0.00	1.66	9.94	0.99	0.00	0.00	0.66	4.64
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	0.00	0.00	2.06	12.50	0.97	0.00	0.00	1.46	4.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	0.00	0.00	2.22	10.41	1.21	0.00	0.00	1.21	4.35
hepatoma cell line:Li-7	10484-107A7	6.90	0.56	9.34	16.13	1.33	0.89	0.22	0.22	3.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	1.31	0.00	0.80	0.00	0.40	1.31	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	7.57	0.00	25.55	11.36	0.95	0.95	0.95	0.95	3.79
hippocampus, adult, donor10252	10153-102I9	1.63	5.10	43.68	30.21	0.82	0.61	0.61	1.63	33.27
hippocampus, adult, donor10258	10374-105G5	1.49	1.99	21.91	2.49	0.00	0.00	0.00	0.50	1.00
hippocampus, newborn, donor10223	10363-105F3	2.47	2.11	27.49	3.52	0.00	0.35	0.70	0.35	2.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	0.61	0.00	1.22	0.61	0.61	1.22	0.00	0.00	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	1.37	0.59	1.37	0.79	0.00	1.57	0.00	0.39	3.14
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	2.29	0.00	0.76	1.02	0.00	0.25	0.00	0.25	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	0.56	0.00	0.56	0.56	0.56	0.00	0.00	0.00	6.20
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	0.52	0.00	0.00	0.52	0.77	0.00	0.00	0.00	5.42
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	0.76	0.38	0.38	0.00	0.76	0.00	0.00	0.00	4.93
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	0.29	0.29	2.63	4.96	0.00	0.29	0.00	0.58	8.47
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	1.51	0.00	1.29	4.52	0.43	0.00	0.00	0.00	8.40
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	1.25	0.42	1.67	2.92	0.00	0.00	0.00	0.00	4.59
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	2.84	0.00	1.89	2.13	0.24	0.47	0.00	0.24	5.21
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	1.29	0.32	1.77	1.61	0.32	0.32	0.00	0.32	5.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	2.69	0.67	4.71	2.69	0.67	0.67	0.00	2.02	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	0.63	0.00	0.47	1.10	0.31	0.63	0.00	0.31	3.60
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	0.00	0.49	0.98	2.46	0.49	0.00	0.00	0.00	2.95
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	0.00	0.00	0.00	1.75	0.87	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	0.19	0.38	0.19	0.57	0.57	0.19	0.19	0.00	5.54
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	1.31	0.44	1.74	0.87	0.44	0.00	0.00	0.00	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	0.50	0.00	0.00	1.50	0.50	0.00	0.00	0.00	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	0.19	0.38	1.70	1.88	0.00	0.19	0.19	0.57	10.93
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	0.45	1.82	1.36	0.91	0.45	0.00	0.00	0.91	7.28
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	0.00	0.31	1.57	2.82	0.00	0.00	0.00	0.00	5.95
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	0.16	0.33	3.10	0.98	0.16	0.00	0.33	0.00	6.53
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	0.29	0.29	1.16	2.32	0.00	0.00	0.29	0.87	6.10
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	0.30	1.20	2.09	1.79	0.00	0.00	0.00	0.90	5.38
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	1.66	0.00	1.29	1.66	0.55	0.74	0.00	0.00	5.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	1.43	0.57	1.14	0.57	0.00	0.86	0.00	0.00	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	1.22	0.41	2.86	1.22	0.41	1.63	0.00	0.00	3.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	2.11	0.35	0.35	0.35	0.35	0.00	0.00	0.00	4.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	0.32	0.32	0.63	0.95	0.00	0.32	0.00	0.00	3.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	2.42	0.61	1.51	0.61	0.61	0.30	0.00	0.00	3.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	3.10	0.00	1.55	2.59	0.52	0.00	0.00	0.52	5.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	0.66	0.00	2.66	1.99	0.00	0.00	0.00	0.00	4.65
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	1.80	0.26	2.57	1.80	0.26	0.00	0.00	0.77	5.64
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	2.30	0.77	3.07	2.56	0.26	0.00	0.00	0.51	5.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	0.00	0.76	5.30	1.51	0.00	0.00	0.00	0.00	6.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	0.67	0.00	4.03	2.02	1.01	0.00	0.67	1.34	3.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1.21	0.00	0.97	0.97	0.72	0.00	0.00	0.00	5.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	0.89	0.45	1.34	0.89	1.34	0.00	0.00	0.45	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	0.00	0.00	0.49	1.95	0.98	0.49	0.49	0.00	4.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	0.31	0.00	0.61	0.61	0.31	0.61	0.00	0.00	5.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	0.00	0.00	3.25	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	0.33	0.00	0.00	1.32	0.00	0.33	0.00	0.00	4.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	0.55	0.00	0.00	1.09	0.00	0.00	0.00	0.55	4.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	1.09	0.36	0.00	3.62	0.36	0.00	0.00	0.36	5.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	0.71	0.00	1.78	1.42	0.36	0.00	0.00	0.00	4.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	2.39	0.00	1.19	1.19	2.39	0.00	0.00	0.00	4.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	0.27	0.81	2.57	0.95	0.41	0.14	0.14	0.81	6.50
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	0.54	0.54	2.42	0.81	0.54	0.00	0.00	0.00	4.58
immature langerhans cells, donor1	11904-125F5	190.57	14.53	24.94	32.45	7.99	25.43	4.84	4.84	1.94
immature langerhans cells, donor2	11905-125F6	289.13	15.05	24.56	19.01	20.60	25.35	7.13	13.47	0.79
insula, adult, pool1	10039-101F3	2.46	1.32	60.28	6.91	1.32	0.19	0.19	1.99	6.62
keratoacanthoma cell line:HKA-1	10791-110H8	118.68	0.00	16.58	0.00	6.18	1.63	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	10.11	2.00	14.42	6.71	3.80	0.50	0.20	3.10	2.50
kidney, fetal, pool1	10045-101F9	9.05	1.98	9.97	6.01	5.52	2.12	0.35	3.89	4.46
large cell lung carcinoma cell line:IA-LM	10509-107D5	429.19	55.96	22.16	28.55	30.68	39.77	8.10	10.08	3.41
large cell lung carcinoma cell line:NCI-H460	10839-111E2	4.42	8.16	2.90	0.41	1.94	0.83	1.66	0.41	1.38
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	113.77	5.14	6.79	23.67	5.14	9.36	1.28	0.92	1.28
left atrium, adult, donor1	10079-102A7	8.72	4.90	2.72	7.08	1.09	0.54	1.63	6.54	1.63
left ventricle, adult, donor1	10078-102A6	16.18	4.55	3.03	21.24	2.53	1.01	3.54	7.08	2.53
leiomyoblastoma cell line:G-402	10721-110A1	0.00	15.05	9.30	0.55	0.00	0.00	2.46	0.27	7.11
leiomyoma cell line:10964C	10569-108B2	7.54	17.24	5.75	7.18	5.39	1.44	6.83	3.59	2.16
leiomyoma cell line:15242A	10570-108B3	25.00	6.52	10.33	10.87	5.98	3.26	3.80	3.26	2.17
leiomyoma cell line:15425	10571-108B4	13.60	21.61	6.07	7.77	5.58	1.46	7.04	4.13	1.70
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	12.70	12.70	0.00	12.70	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	61.69	5.23	7.32	15.68	4.18	6.27	4.18	2.09	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	82.52	0.24	24.79	8.03	4.49	14.99	0.12	6.73	0.24
liposarcoma cell line:KMLS-1	10782-110G8	82.32	16.25	15.31	12.81	9.53	7.65	5.31	10.00	8.28
liposarcoma cell line:SW 872	10726-110A6	24.12	20.59	18.52	1.83	10.36	2.56	5.73	6.21	5.12
liver, adult, pool1	10018-101C9	1.94	0.65	0.97	13.78	12.80	0.32	0.49	3.08	1.78
liver, fetal, pool1	10086-102B5	0.00	0.94	2.82	1.88	1.88	0.94	0.00	0.00	1.88
locus coeruleus - adult, donor10196	10182-103D2	8.75	2.19	13.56	8.46	0.58	0.87	0.29	1.31	7.87
locus coeruleus, adult, donor10252	10165-103B3	5.35	1.48	20.12	11.26	1.11	0.55	0.55	1.11	15.87
locus coeruleus, adult, donor10258	10375-105G6	2.82	2.82	12.13	7.05	0.56	1.41	1.13	2.54	6.49
locus coeruleus, newborn, donor10223	10362-105F2	2.52	1.68	8.41	4.21	0.00	0.84	0.42	0.00	2.10
lung adenocarcinoma cell line:A549	10499-107C4	38.06	19.38	4.98	1.52	3.88	3.74	3.32	0.28	2.08
lung adenocarcinoma cell line:PC-14	10408-106B3	89.62	6.89	19.30	2.07	7.58	4.14	0.69	1.38	3.45
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	146.18	8.70	9.36	7.65	9.49	15.03	1.32	3.82	2.77
lung, adult, pool1	10019-101D1	27.05	4.73	10.16	4.25	7.21	3.19	2.36	5.55	2.60
lung, fetal, donor1	10068-101I5	30.82	1.71	6.85	2.85	6.85	2.00	0.00	4.57	2.28
lung, right lower lobe, adult, donor1	10075-102A3	36.20	7.33	12.83	2.29	5.96	2.75	2.75	11.91	3.21
lymph node, adult, donor1	10077-102A5	17.99	4.26	8.99	8.05	6.15	2.84	1.89	3.79	1.89
lymphangiectasia cell line:DS-1	10727-110A7	3.95	8.77	4.82	2.63	3.73	1.75	2.41	2.41	1.53
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	11.32	0.00	1.36	1.66	0.00	3.92	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	528.39	21.24	28.03	0.85	6.80	16.99	3.40	1.70	0.00
mature adipocyte, donor1	12231-129F8	9.77	2.22	15.10	6.22	2.66	1.33	0.44	0.89	0.89
mature adipocyte, donor2	12232-129F9	13.90	0.83	14.11	2.49	2.28	0.62	0.00	1.45	1.25
mature adipocyte, donor3	12233-129G1	6.87	0.95	14.22	3.08	0.95	0.71	0.47	1.90	1.90
mature adipocyte, donor4	12234-129G2	3.95	0.26	9.21	1.84	0.79	0.79	0.00	0.53	1.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	10.48	3.10	4.77	1.43	3.34	1.43	0.48	2.86	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	6.77	1.13	27.07	3.38	0.00	0.00	0.00	0.00	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	2.39	4.97	41.93	10.30	0.92	0.55	0.37	0.55	18.94
medial frontal gyrus, adult, donor10258	10368-105F8	1.27	0.64	25.73	5.40	0.32	0.00	0.00	0.00	3.18
medial frontal gyrus, newborn, donor10223	10352-105E1	1.28	0.43	26.87	5.12	0.43	0.00	0.00	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	2.19	1.52	23.96	5.91	0.84	1.18	0.51	0.51	4.22
medial temporal gyrus, adult, donor10252	10156-103A3	2.97	2.97	40.53	10.82	0.85	0.21	0.21	1.27	15.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	0.00	38.53	5.78	0.00	0.00	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	28.71	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	3.59	1.79	35.53	5.38	0.72	0.00	0.36	0.36	0.72
medulla oblongata - adult, donor10196	10174-103C3	7.79	1.30	11.68	9.73	2.60	0.00	1.95	2.60	4.54
medulla oblongata, adult, donor10252	10155-103A2	3.25	3.25	22.91	15.48	4.64	0.77	1.39	3.72	24.30
medulla oblongata, adult, pool1	10038-101F2	9.31	4.16	24.81	12.98	1.96	1.06	0.41	4.08	16.82
medulla oblongata, newborn, donor10223	10361-105F1	6.60	7.64	19.09	9.37	2.43	0.00	1.74	2.78	10.07
medulloblastoma cell line:D283 Med	10838-111E1	0.22	0.00	4.65	4.87	0.44	0.00	0.00	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	76.91	7.58	11.25	19.20	2.45	8.56	1.35	0.24	1.71
melanoma cell line:COLO 679	10514-107E1	0.43	16.53	10.78	0.00	0.43	0.14	4.17	1.15	0.86
melanoma cell line:G-361	10465-106H6	13.03	71.67	32.85	1.36	5.97	1.90	13.30	3.53	1.90
meningioma cell line:HKBMM	10691-109F7	119.94	16.46	13.21	21.17	12.30	8.14	6.69	7.24	4.52
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.00	0.88	0.88	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	4.15	0.52	5.18	5.70	2.33	1.04	0.00	1.04	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	20.71	31.91	5.98	1.38	5.06	4.45	8.75	5.22	3.53
mesenchymal precursor cell - adipose, donor2	11748-123G2	8.54	12.54	4.91	1.09	4.18	1.45	2.36	4.36	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.42	39.75	3.31	0.83	3.73	2.90	11.18	4.14	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	5.76	19.10	5.62	2.95	5.62	0.98	6.46	2.39	3.23
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	9.63	16.37	2.70	2.12	5.78	2.89	4.04	3.08	3.85
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	26.37	29.15	11.80	0.00	10.41	0.69	11.80	5.55	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	11.67	19.22	3.78	0.69	4.81	1.54	8.24	1.89	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	12.54	44.97	7.36	1.50	5.98	1.50	12.88	2.88	5.29
mesenchymal precursor cell - cardiac, donor3	11754-123G8	15.25	30.11	8.36	1.19	4.11	2.92	8.62	3.98	2.65
mesenchymal precursor cell - cardiac, donor4	11755-123G9	2.97	9.05	2.16	1.89	2.43	0.14	3.38	0.95	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	38.98	14.94	8.82	7.97	3.13	6.54	5.26	2.42	2.13
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	12.19	14.16	4.94	6.59	0.99	1.65	2.63	1.65	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	35.15	18.13	5.95	5.81	3.32	6.09	5.67	3.32	2.08
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	42.59	59.69	9.77	0.35	6.98	3.84	15.01	7.68	4.89
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	60.64	21.85	9.80	2.86	4.49	10.21	6.33	3.47	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	47.45	14.38	7.19	14.02	5.39	4.31	4.67	6.11	2.16
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	62.48	14.79	6.62	0.93	5.59	11.48	5.28	2.79	1.97
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	88.23	15.50	13.22	1.37	3.42	7.52	6.84	2.74	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	49.09	17.62	5.45	5.87	2.10	7.55	7.13	1.26	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	8.07	8.37	4.78	14.05	2.54	1.49	2.54	2.69	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	42.80	8.23	6.30	3.15	4.90	6.13	3.33	2.63	3.24
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	20.99	17.67	8.84	3.68	8.47	4.42	5.52	4.42	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	43.78	14.02	12.30	17.74	4.86	5.15	3.43	3.15	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	63.99	33.68	8.00	18.10	1.26	6.32	8.84	3.37	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	26.03	30.60	12.33	3.65	7.76	4.57	10.50	5.48	2.74
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	21.49	27.37	8.95	2.81	8.95	2.30	9.72	6.39	3.07
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.20	29.58	6.54	3.66	8.38	1.83	11.78	7.59	4.19
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	24.96	38.82	5.85	3.39	8.93	1.54	10.17	7.70	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	18.83	26.12	9.18	4.71	7.77	0.94	7.53	3.29	3.06
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	27.08	34.52	9.14	5.42	7.78	0.68	7.78	4.40	2.03
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	22.79	31.44	10.61	4.72	7.47	1.57	6.29	3.14	3.14
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	23.17	29.66	8.80	3.71	7.88	2.32	10.66	6.02	2.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	96.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	28.26	36.63	15.00	5.77	10.09	3.75	7.79	8.08	4.04
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	25.66	35.03	12.05	4.02	5.80	2.23	7.81	7.59	3.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	24.28	31.25	9.61	5.53	6.97	2.88	11.54	7.21	5.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	22.00	33.00	14.67	8.07	11.00	0.73	13.20	8.80	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	21.82	26.18	11.08	2.69	5.37	1.01	11.75	6.04	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	21.29	21.70	9.83	4.50	4.91	0.82	9.42	6.14	3.28
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	30.07	33.08	10.31	1.29	8.59	1.29	9.02	6.87	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	21.88	5.47	0.00	8.20	0.00	16.41	5.47	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16	5.16	5.16	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	18.51	21.11	7.47	2.92	7.15	2.27	2.60	6.17	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	8.73	1.45	5.82	7.27	0.00	2.91	2.91	7.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	20.26	17.59	8.53	2.67	7.46	1.60	6.40	7.46	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.00	18.81	7.36	0.00	4.91	3.27	5.72	9.81	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	20.60	19.44	8.55	4.28	7.77	1.55	10.11	6.22	3.11
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	6.30	4.20	6.30	4.20	2.10	4.20	12.59	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	21.86	5.96	3.97	7.95	1.99	5.96	2.98	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	9.53	4.77	4.77	4.77	0.00	19.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	16.60	12.45	4.74	1.78	6.52	0.59	4.15	2.96	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	18.28	28.02	6.09	3.66	7.31	1.22	3.66	7.31	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.23	19.00	8.23	2.53	8.23	0.63	3.80	6.33	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	11.73	7.93	8.97	1.72	5.17	1.38	3.10	6.21	3.79
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2.15	10.75	2.15	0.00	4.30	0.00	0.00	4.30	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	11.98	3.99	0.00	3.99	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	13.78	3.44	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	5.30	14.26	6.93	1.22	6.52	0.41	2.04	1.63	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	2.38	14.30	4.77	1.59	5.56	0.00	1.59	3.97	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	0.59	8.25	6.48	3.54	1.77	0.00	0.59	3.54	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	0.94	11.22	5.61	3.74	0.94	0.31	2.81	3.12	1.87
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	4.01	9.36	4.01	4.01	0.00	1.34	6.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	2.37	8.28	14.19	4.73	8.28	0.00	4.73	2.37	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	5.14	2.57	10.27	0.00	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	2.75	8.95	6.88	3.44	0.00	0.00	2.07	1.38	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	1.98	0.49	4.95	1.98	2.47	0.99	0.99	1.48	2.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	1.12	5.61	6.73	5.61	2.24	0.00	0.00	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1.27	1.91	2.54	1.91	0.00	0.00	0.00	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	0.40	1.21	2.42	1.21	0.00	0.00	0.00	0.40	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	6.54	2.18	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	2.53	0.00	5.07	1.27	0.00	0.00	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	0.61	0.00	2.43	4.25	0.00	0.00	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	0.00	0.00	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	4.12	0.82	3.29	3.29	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	1.19	6.94	2.18	2.78	3.37	0.00	1.59	2.18	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	1.95	6.49	6.17	4.54	4.22	0.00	1.95	3.24	3.89
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	3.06	8.15	6.11	8.15	2.04	0.00	4.07	1.02	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	40.23	27.85	22.44	27.85	9.28	1.55	6.19	9.28	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	113.63	19.14	21.97	13.47	5.91	15.36	4.25	1.89	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	49.81	5.79	5.33	4.87	9.50	2.32	1.62	3.01	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	17.09	17.09	25.64	4.27	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	49.22	20.14	6.78	21.99	1.64	3.60	6.27	1.03	0.41
mesothelioma cell line:Mero-25	10850-111F4	17.48	6.58	2.50	1.59	0.68	1.36	0.68	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	208.78	29.83	18.58	19.80	9.29	11.00	10.51	4.89	1.96
mesothelioma cell line:Mero-48a	10852-111F6	288.08	28.34	23.47	45.84	11.29	27.46	8.19	7.97	0.44
mesothelioma cell line:Mero-82	10853-111F7	182.12	16.82	13.67	57.29	8.15	7.88	5.52	1.84	1.58
mesothelioma cell line:Mero-83	10854-111F8	95.32	32.85	13.45	7.49	6.47	8.68	8.00	3.23	1.87
mesothelioma cell line:Mero-84	10855-111F9	73.05	30.33	9.10	2.02	4.55	5.56	9.35	1.77	2.27
mesothelioma cell line:Mero-95	10856-111G1	39.13	5.80	6.83	3.31	3.73	3.73	2.90	1.66	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	157.20	29.98	19.05	14.91	5.47	19.88	6.79	2.98	2.32
mesothelioma cell line:NCI-H226	10846-111E9	55.38	13.39	5.07	1.45	3.62	3.98	3.98	1.63	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	50.91	16.74	5.47	4.61	3.93	5.12	5.12	1.37	3.42
mesothelioma cell line:NCI-H28	10845-111E8	8.40	10.94	2.54	4.58	0.25	3.82	2.80	0.51	0.76
mesothelioma cell line:No36	10857-111G2	36.53	13.05	6.20	0.65	4.57	2.61	3.91	1.96	0.00
mesothelioma cell line:ONE58	10858-111G3	71.80	11.11	7.59	24.39	4.88	4.34	4.34	2.44	2.44
migratory langerhans cells, donor1	11901-125F2	25.53	5.57	21.30	40.69	2.88	3.07	0.96	0.58	0.19
migratory langerhans cells, donor2	11902-125F3	139.46	9.65	34.68	46.89	5.62	13.92	1.47	1.59	0.00
migratory langerhans cells, donor3	11903-125F4	73.23	3.23	42.00	15.44	1.79	8.62	0.72	1.26	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	11.43	9.14	10.77	12.73	2.29	0.98	2.29	2.61	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	111.69	15.90	8.48	34.12	5.09	18.44	6.36	2.33	2.12
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	480.76	7.37	5.07	29.95	11.52	15.89	1.38	2.53	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	26.64	24.36	11.23	0.00	1.14	9.70	4.76	1.33	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	12.94	0.00	32.71	0.18	0.00	4.25	0.00	0.00	0.00
myeloma cell line:PCM6	10474-106I6	38.94	0.00	3.95	0.40	1.19	2.17	0.00	1.38	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	182.12	9.13	13.19	15.73	7.10	13.70	4.06	4.57	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	2.35	39.03	5.88	6.67	3.53	0.39	13.14	4.71	3.92
nasal epithelial cells, donor1, tech_rep1	12226-129F3	78.89	1.67	6.91	2.56	1.11	3.57	0.22	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	66.19	1.25	6.55	1.99	1.69	2.43	0.07	0.00	0.15
nasal epithelial cells, donor2	12227-129F4	215.83	9.38	9.94	6.62	3.86	10.49	3.31	1.10	0.55
neuroblastoma cell line:CHP-134	10508-107D4	0.00	0.00	0.23	0.23	0.46	0.00	0.00	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	0.19	20.02	12.72	2.06	1.12	0.00	3.37	0.56	9.92
neuroblastoma cell line:NBsusSR	10607-108F4	4.01	0.00	5.06	6.75	1.05	0.42	0.00	0.42	1.48
neuroblastoma cell line:NH-12	10555-107I6	0.19	0.00	0.19	0.37	0.56	0.19	0.00	0.00	1.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.24	0.00	0.47	2.85	2.14	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	19.48	12.51	18.53	14.41	3.33	2.69	2.22	2.06	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	9.66	0.00	5.23	6.64	1.01	3.22	0.00	1.21	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	27.34	17.80	13.99	5.72	5.09	10.81	2.54	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	96.88	34.07	15.97	11.18	15.97	7.45	10.91	12.51	1.60
neutrophil PMN, donor1	12133-128D9	446.24	0.00	832.99	0.00	193.37	133.87	0.00	0.00	14.87
neutrophil PMN, donor2	12137-128E4	0.00	0.00	26.56	0.00	0.00	26.56	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	18.94	0.00	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	0.34	0.00	1.18	2.71	0.17	0.00	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.00	4.80	15.21	0.80	0.80	0.00	0.00	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	24.37	26.29	11.22	10.90	13.79	1.28	8.34	10.26	4.49
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	60.70	12.61	12.88	28.64	2.63	4.73	6.31	4.99	5.52
nucleus accumbens, adult, pool1	10037-101F1	2.25	1.31	48.46	6.94	1.78	0.28	0.19	1.97	6.47
occipital cortex - adult, donor10196	10172-103C1	0.00	0.00	24.72	0.00	0.00	0.00	0.00	0.00	4.12
occipital cortex, adult, donor10252	10163-103B1	4.03	3.22	52.33	16.37	0.81	0.27	0.81	2.68	18.79
occipital cortex, newborn, donor10223	10355-105E4	3.28	2.18	31.66	4.73	0.73	0.00	0.73	1.09	1.82
occipital lobe, adult, donor1	10076-102A4	4.72	1.84	18.89	5.25	1.31	0.79	0.00	0.79	3.15
occipital lobe, fetal, donor1	10073-102A1	0.43	0.00	12.01	0.43	0.43	0.43	0.00	1.29	3.00
occipital pole, adult, pool1	10036-101E9	2.05	0.71	48.88	6.39	0.55	0.24	0.16	1.97	5.12
olfactory region, adult	10195-103E6	0.96	1.72	30.57	10.51	1.15	0.19	0.38	3.63	8.22
optic nerve, donor1	10277-104E7	4.00	4.00	10.01	2.00	4.00	0.00	0.00	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	101.83	4.21	11.96	13.33	1.71	3.76	1.37	0.80	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	53.44	1.24	14.70	10.30	2.47	4.67	0.00	0.82	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	145.11	5.08	9.82	11.01	6.94	6.94	2.20	1.02	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	158.48	12.01	8.09	18.37	5.08	21.83	2.89	0.81	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	87.01	24.40	11.17	9.41	11.17	5.29	9.41	7.35	1.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	199.01	46.72	19.62	7.47	14.95	25.23	9.34	8.41	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	117.48	56.83	39.02	49.83	12.30	10.18	11.88	17.18	0.00
ovary, adult, pool1	10020-101D2	4.89	14.59	6.99	17.38	11.36	0.79	2.10	9.35	8.65
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	17.42	11.37	5.32	6.60	2.02	1.83	2.20	2.38	0.00
pancreas, adult, donor1	10049-101G4	3.76	0.00	9.41	7.53	15.05	0.00	0.00	7.53	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	12.86	0.00	8.39	19.01	0.00	1.12	0.00	0.00	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	132.71	12.78	18.06	0.00	6.98	5.96	4.77	2.21	2.21
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	227.18	4.97	6.79	42.22	9.44	9.60	1.16	2.81	1.66
paracentral gyrus, adult, pool1	10035-101E8	3.75	0.64	46.95	6.86	1.01	0.18	0.18	1.01	3.94
parietal cortex, adult, donor10258	10373-105G4	0.73	0.00	24.22	1.47	1.47	0.00	0.00	0.73	2.94
parietal lobe - adult, donor10196	10171-103B9	3.76	0.94	19.75	3.76	0.94	0.94	0.00	1.88	3.76
parietal lobe, adult, donor10252	10157-103A4	1.43	2.57	48.46	10.26	0.29	0.29	0.00	1.14	12.83
parietal lobe, adult, pool1	10034-101E7	2.91	0.97	51.02	7.40	0.88	0.53	0.18	1.59	5.55
parietal lobe, fetal, donor1	10072-101I9	0.00	0.00	6.79	3.88	0.97	0.00	0.00	1.94	4.85
parietal lobe, newborn, donor10223	10356-105E5	2.24	2.24	25.05	7.10	0.37	0.00	0.37	0.00	0.37
parotid gland, adult	10199-103F1	17.27	1.23	6.17	6.78	30.22	1.23	0.62	12.33	4.93
penis, adult	10200-103F2	29.00	16.11	10.74	24.17	15.58	3.76	2.69	17.72	4.30
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	46.86	6.69	7.81	1.49	4.46	11.16	1.30	1.30	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	81.01	7.43	12.97	35.26	7.87	5.54	3.21	5.68	0.00
pineal gland - adult, donor10196	10179-103C8	1.94	16.77	9.68	3.23	10.97	0.00	1.29	3.87	2.58
pineal gland, adult, donor10252	10160-103A7	1.18	5.92	6.51	3.55	4.74	0.59	0.00	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	1.88	5.02	10.03	4.39	1.25	0.00	1.88	1.88	3.76
pituitary gland - adult, donor10196	10180-103C9	11.13	6.07	9.11	1.01	7.08	0.00	1.01	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	7.82	2.08	9.38	2.61	8.86	1.04	0.00	3.65	2.08
pituitary gland, adult, donor10258	10378-105G9	1.70	0.85	8.51	0.85	11.07	0.85	0.00	0.00	1.70
placenta, adult, pool1	10021-101D3	27.63	4.62	7.74	59.77	3.33	2.69	0.75	2.58	2.90
plasma cell leukemia cell line:ARH-77	10840-111E3	1.46	0.26	4.50	1.46	0.40	2.91	0.00	0.40	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	72.53	5.60	10.58	16.81	6.54	2.80	1.87	6.54	3.27
pons, adult, pool1	10033-101E6	5.08	0.86	21.78	3.87	0.69	0.60	0.17	1.38	8.78
postcentral gyrus, adult, pool1	10032-101E5	2.27	1.39	49.43	5.84	0.70	0.35	0.00	1.57	6.19
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	0.00	20.91	0.00	0.00	0.00	0.00	4.18	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	64.82	6.85	4.81	6.99	4.37	9.18	2.33	1.46	3.35
prostate cancer cell line:PC-3	10439-106E7	283.69	13.43	21.96	14.88	11.25	16.70	3.27	4.17	7.62
prostate, adult, pool1	10022-101D4	11.16	3.45	12.52	16.96	9.34	0.91	0.73	4.72	5.44
putamen, adult, donor10196	10176-103C5	6.37	0.47	36.12	2.60	1.65	0.00	0.00	1.18	7.32
putamen, adult, donor10252	10152-102I8	0.00	0.00	78.43	1.96	1.96	0.00	1.96	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	1.09	0.00	19.67	3.28	1.09	0.00	0.00	1.09	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	1.69	0.24	37.93	3.38	0.48	0.48	0.48	0.97	2.66
putamen, newborn, donor10223	10365-105F5	2.25	0.75	6.75	1.50	0.75	0.00	0.75	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	77.97	3.78	6.11	5.24	10.47	3.20	0.87	1.16	0.58
rectum, fetal, donor1	10067-101I4	18.08	1.39	16.69	23.65	4.17	4.17	1.39	13.91	5.56
renal cell carcinoma cell line:OS-RC-2	10411-106B6	22.26	4.24	6.78	3.82	2.54	6.15	2.12	0.64	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	14.08	0.00	5.38	7.04	2.49	5.38	0.00	0.00	1.66
retina, adult, pool1	10030-101E3	7.16	2.78	20.28	24.45	5.67	1.19	0.70	6.46	6.46
retinoblastoma cell line:Y79	10475-106I7	0.00	0.00	4.68	5.72	0.00	0.00	0.00	0.00	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	3.57	4.92	0.00	0.00	0.00	0.12	0.00	7.75
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	0.56	36.27	3.66	12.65	0.84	0.00	3.09	1.41	3.09
sacrococcigeal teratoma cell line:HTST	10695-109G2	32.59	12.88	21.98	4.55	9.85	0.76	3.79	8.34	2.27
salivary acinar cells, donor1	11771-123I7	126.57	4.86	12.62	4.86	4.05	4.86	1.62	1.29	4.86
salivary acinar cells, donor2	11772-123I8	133.28	5.78	23.96	15.83	5.37	7.02	3.03	3.30	2.20
salivary acinar cells, donor3	11773-123I9	167.50	5.96	24.50	11.25	13.90	2.65	0.00	3.97	1.99
salivary gland, adult, pool1	10093-102C3	6.86	0.00	8.01	8.58	29.74	1.14	0.00	13.15	3.43
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	50.92	18.55	4.97	0.59	2.61	6.74	3.37	2.53	1.60
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	51.02	19.04	5.05	0.59	2.35	8.58	3.29	2.47	1.06
seminal vesicle, adult	10201-103F3	8.47	3.70	11.11	19.58	13.76	1.06	0.53	5.29	5.82
serous adenocarcinoma cell line:JHOS-2	10639-108I9	442.85	14.82	30.37	30.37	28.91	31.34	4.86	8.02	4.86
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	70.21	9.56	16.36	0.00	5.79	4.78	1.51	3.77	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	144.51	22.08	14.05	0.00	3.01	6.02	3.01	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	151.24	0.94	10.61	3.90	7.66	13.84	0.00	2.28	1.48
signet ring carcinoma cell line:Kato III	10436-106E4	200.61	6.74	6.52	18.57	4.20	6.19	2.10	1.11	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	72.25	9.03	3.87	12.00	4.26	4.64	1.55	2.45	2.58
skeletal muscle - soleus muscle, donor1	10282-104F3	9.93	4.26	1.42	52.49	1.42	0.00	0.71	9.22	1.42
skeletal muscle, adult, pool1	10023-101D5	8.76	4.32	3.00	50.85	2.76	0.60	1.68	11.39	2.16
skeletal muscle, fetal, donor1	10066-101I3	8.04	12.06	2.01	40.20	4.02	0.00	7.04	15.08	9.05
skin, adult, donor1	10074-102A2	61.07	6.79	0.00	0.00	6.79	6.79	0.00	13.57	0.00
skin, fetal, donor1	10065-101I2	35.98	1.89	7.57	13.26	8.84	3.79	1.26	10.73	5.05
small cell cervical cancer cell line:HCSC-1	10800-110I8	0.00	0.00	2.00	3.00	0.67	0.00	0.00	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	0.00	1.58	16.71	7.56	0.95	0.00	0.00	1.58	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	0.39	0.58	8.10	0.19	0.00	0.00	0.00	0.19	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	7.25	0.00	1.32	2.31	1.48	1.32	0.00	0.66	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	0.16	0.16	1.61	1.45	0.32	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	0.22	0.00	5.23	5.67	1.74	0.00	0.00	0.87	1.09
small intestine, adult, pool1	10024-101D6	97.94	2.99	8.72	19.83	9.56	4.78	0.96	4.30	3.34
small intestine, fetal, donor1	10064-101I1	27.03	2.21	2.21	9.34	6.88	1.97	0.00	3.93	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	1.54	9.75	15.39	3.59	6.15	0.00	2.05	2.56	3.59
smooth muscle, adult, pool1	10048-101G3	7.75	8.01	6.20	52.72	12.41	1.03	1.81	8.53	5.17
somatostatinoma cell line:QGP-1	10781-110G7	0.00	0.00	9.92	0.00	4.82	0.00	0.00	1.61	0.80
spinal cord - adult, donor10196	10181-103D1	5.74	2.06	10.78	12.62	1.15	0.46	0.69	3.44	9.18
spinal cord, adult, donor10252	10159-103A6	2.76	3.15	13.80	19.71	1.58	0.79	1.58	2.37	16.56
spinal cord, adult, donor10258	10369-105F9	2.08	2.08	11.76	6.92	0.00	0.00	0.00	0.69	1.38
spinal cord, fetal, donor1	10056-101H2	4.88	3.66	37.20	28.05	1.83	0.00	3.66	15.25	22.56
spinal cord, newborn, donor10223	10359-105E8	1.38	1.38	15.15	9.18	0.00	0.00	0.00	2.30	5.97
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	102.91	44.21	14.79	10.45	16.88	6.12	17.62	8.81	1.49
spleen, adult, pool1	10025-101D7	15.53	3.19	11.89	3.30	5.95	3.08	1.32	4.63	5.62
spleen, fetal, pool1	10044-101F8	20.34	5.01	14.62	6.20	8.50	3.50	0.56	4.53	8.58
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.10	0.00	14.39	1.35	0.83	0.00	0.00	0.10	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	56.39	0.57	6.08	6.65	2.85	3.61	0.19	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	48.92	1.40	5.24	11.88	2.45	6.29	1.05	5.24	2.45
squamous cell carcinoma cell line:T3M-5	10616-108G4	362.78	8.21	26.97	23.46	16.42	27.76	0.78	2.74	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	205.53	14.97	11.14	45.25	20.60	13.28	5.07	5.52	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	18.64	17.79	6.78	4.24	1.27	0.42	4.24	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	144.27	10.15	4.65	6.77	2.54	12.69	3.81	1.27	0.42
stomach, fetal, donor1	10062-101H8	43.79	4.27	5.34	8.54	8.54	2.14	1.07	8.54	6.41
submaxillary gland, adult	10202-103F4	22.79	1.71	17.66	7.98	23.93	1.14	0.57	12.53	2.28
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	4.98	2.08	12.46	15.79	1.04	0.83	0.62	2.08	12.88
substantia nigra, adult, donor10258	10371-105G2	2.59	1.55	16.55	5.69	0.00	0.52	0.00	0.52	3.10
substantia nigra, newborn, donor10223	10358-105E7	3.53	3.53	14.13	3.53	2.12	0.00	2.12	0.71	3.53
synovial sarcoma cell line:HS-SY-II	10441-106E9	1.15	6.65	19.95	5.73	2.29	0.23	1.83	0.69	3.67
temporal lobe, adult, pool1	10031-101E4	2.54	2.12	46.37	7.63	0.85	0.25	0.25	1.27	8.31
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	0.00	0.00	11.40	2.85	0.71	0.00	0.00	0.71	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	7.91	1.76	14.94	3.52	1.32	1.32	0.44	0.44	2.20
tenocyte, donor1	11763-123H8	48.18	25.14	7.68	4.19	10.47	6.98	9.77	5.59	5.59
tenocyte, donor2	11765-123I1	29.76	14.12	5.72	2.29	7.63	5.34	4.96	4.96	3.82
tenocyte, donor3	11768-123I4	25.21	28.54	8.53	2.22	10.01	2.22	11.12	3.71	2.22
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	1.70	0.00	1.70	3.40	0.51	0.17	0.00	0.51	2.21
teratocarcinoma cell line:NCR-G1	10798-110I6	7.24	0.46	6.17	4.62	2.47	1.08	0.00	0.31	8.32
teratocarcinoma cell line:PA-1	10807-111A6	3.56	1.39	1.55	1.70	0.31	0.46	0.15	0.46	6.04
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	51.67	7.24	4.44	6.09	3.94	3.43	0.76	1.65	2.92
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	32.90	0.38	3.40	1.51	2.27	3.40	0.00	1.13	3.03
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	57.26	1.74	7.63	1.09	3.60	5.45	0.33	1.85	1.31
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	34.20	0.00	2.61	1.30	2.93	6.84	0.00	0.00	2.28
testis, adult, pool1	10026-101D8	8.91	7.09	6.01	9.77	8.16	0.75	0.64	5.48	4.62
testis, adult, pool2	10096-102C6	2.26	3.16	4.96	6.32	3.61	0.45	0.45	4.51	4.06
thalamus - adult, donor10196	10168-103B6	4.42	2.21	16.56	23.18	2.21	0.00	0.00	0.00	6.62
thalamus, adult, donor10252	10154-103A1	1.56	1.56	25.01	20.16	0.78	0.63	1.41	1.09	23.44
thalamus, adult, donor10258, tech_rep1	10370-105G1	0.00	4.62	36.95	6.16	1.54	1.54	0.00	3.08	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	2.80	2.31	16.96	11.03	0.49	0.33	0.16	0.82	8.07
thalamus, newborn, donor10223	10366-105F6	2.88	0.58	12.08	6.33	0.00	0.00	0.00	0.00	2.30
throat, adult	10209-103G2	27.21	4.99	8.99	16.98	8.74	2.00	1.75	11.24	2.25
throat, fetal, donor1	10061-101H7	16.15	3.96	5.79	10.36	7.31	1.22	0.30	9.45	2.74
thymic carcinoma cell line:Ty-82	10803-111A2	1.99	0.00	26.63	3.78	0.00	0.79	0.00	0.40	0.00
thymus, adult, pool1	10027-101D9	30.52	0.99	18.19	8.35	9.94	15.41	0.30	2.88	0.10
thymus, fetal, pool1	10043-101F7	27.33	1.66	21.20	16.21	8.42	13.61	0.31	3.32	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	48.80	17.68	10.77	13.56	4.65	5.85	4.65	2.79	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	131.73	6.98	10.06	21.23	3.35	7.96	1.96	2.93	1.54
thyroid, adult, pool1	10028-101E1	6.44	2.15	6.25	3.73	6.16	0.75	0.19	2.43	0.93
thyroid, fetal, donor1	10060-101H6	9.76	3.16	6.33	8.17	3.95	1.58	0.79	7.38	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	70.83	6.16	9.24	24.64	30.80	0.00	6.16	18.48	3.08
tongue, adult	10203-103F5	58.14	7.44	4.88	19.30	6.98	2.79	2.33	10.47	0.93
tongue, fetal, donor1	10059-101H5	21.68	5.52	3.55	24.43	3.94	2.36	1.58	9.85	1.58
tonsil, adult, pool1	10047-101G2	67.52	4.61	19.33	13.02	10.42	8.82	0.60	6.01	1.90
trachea, adult, pool1	10029-101E2	42.29	10.55	7.28	11.62	11.21	3.52	1.88	7.03	3.60
trachea, fetal, donor1	10058-101H4	27.31	2.69	3.08	6.92	13.85	3.08	3.46	13.46	3.85
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	41.80	35.07	10.27	12.75	6.38	2.13	15.23	4.96	2.13
transitional-cell carcinoma cell line:5637	10418-106C4	122.59	1.52	2.74	51.37	1.52	5.98	0.81	0.41	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	125.51	26.48	8.46	19.43	3.92	8.93	4.86	2.19	1.88
tridermal teratoma cell line:HGRT	10694-109G1	125.57	7.61	17.12	13.32	20.93	13.32	1.90	3.81	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	197.07	11.68	8.13	28.61	10.24	5.59	4.23	9.65	2.03
umbilical cord, fetal, donor1	10057-101H3	27.12	10.43	0.00	22.95	4.17	4.17	0.00	6.26	4.17
uterus, adult, pool1	10100-102D1	20.82	11.60	12.46	20.65	14.33	2.22	1.88	10.41	5.63
uterus, fetal, donor1	10055-101H1	19.45	4.61	4.61	7.17	4.10	1.54	0.51	5.12	6.14
vagina, adult	10204-103F6	13.57	3.88	18.09	15.51	12.28	0.65	1.94	3.23	3.23
vein, adult	10191-103E2	22.80	2.85	12.71	7.01	8.77	4.82	0.88	8.33	2.85
xeroderma pigentosum b cell line:XPL 17	10563-108A5	6.14	0.27	7.48	0.27	0.27	2.94	0.00	0.27	0.00